Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
FORMULATION OF CLOMAZONE HAVING REDUCED VOLATILITY
Document Type and Number:
WIPO Patent Application WO/2015/197487
Kind Code:
A2
Abstract:
Herbicidal compositions with clomazone are provided in which clomazone has reduced volatility.

Inventors:
STEINBRENNER ULRICH (DE)
SCHAEFER ANSGAR (DE)
MORAN PUENTE DIANA WESTFALIA (DE)
HENKES STEFFEN (DE)
Application Number:
PCT/EP2015/063813
Publication Date:
December 30, 2015
Filing Date:
June 19, 2015
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
BASF SE (DE)
International Classes:
A01N43/80
Other References:
See references of EP 3160230A2
Attorney, Agent or Firm:
MAIWALD PATENTANWALTS GMBH (Postfach 33 05 23, Munich, DE)
Download PDF:
Claims:
C L A I M S

Use of a compound (B) for reducing the volatility of clomazone in a herbicidal composition, comprising the step of adding the compound (B) to the herbicidal composition comprising clomazone,

wherein compound (B) is defined by the following formula (I)

wherein the substituents R1 , R2, R3, R4 and X are defined as follows:

Ri is selected from hydrogen, linear or branched, saturated or unsaturated, optionally hydroxyl-substituted, alkyl, acyl and halogenated acyl,

R2 is independently selected from linear or branched alkyl, halogenated alkyl, hydroxylated alkyl, alkoxylated alkyl and N-1 H-pyrazol-1 -ylmethyl,

R3 is independently selected from aromatic or non-aromatic C(Rs) with substituent R5 selected from hydrogen or linear or branched, saturated or unsaturated, optionally hydroxy-substituted Ci to C25 alkyl, C(Rs) preferably being selected from non-aromatic -

C(R5), aromatic CH, aromatic C-CH3, aromatic C-CH2-CH3, aromatic C-(CH2)2-CH3, aromatic -C-C(CH3)-CH3; aromatic C-CI, aromatic C-OH and aromatic C-NO2,

R4 is independently selected from aromatic CH-CH-CH, aromatic C(CH3)-CH-

CH, aromatic CH-C(CH3)-CH, aromatic CH-CH-C(CH3), aromatic C(CH3)-C(CH3)-CH, aromatic C(CH3)-CH-C(CH3), aromatic CH-C(CH3)-C(CH3), aromatic CH-S, or is absent, and X is independently selected from aromatic CH, aromatic C-CH3, aromatic C-CH2-

CH3, aromatic C-(CH2)2-CH3, aromatic C-CI, aromatic C-OH, aromatic C-NO2, O, NH, and S.

Use according to claim 1 , wherein the compound (B) is defined by the following formula

(Ma)

wherein R1 and R2 independently represent hydrogen or linear or branched, saturated or unsaturated, optionally hydroxy-substituted Ci to C12 alkyl, preferably methyl, ethyl, propyl or isopropyl and R3 is non-aromatic CR5 wherein R5 is selected from linear or branched, saturated or unsaturated, optionally hydroxy-substituted C5 to C25 alkyl. Use according to claim 2, wherein the compound according to formula (I la) is selected from the fatty acid amides of capronic acid, caprylic acid, capric acid, lauric acid, myrystic acid, palmitic acid, stearic acid, isostearic acid, 12-hydroxy stearic acid, ricinoleic acid, oleic acid, linoleic acid, linolenic acid, gadoleic acid, arachidonic acid, erucic acid, behenic acid, ciric acid, lactic acid and the mixtures thereof, preferably the dimethyl fatty acid amides and their mixtures thereof.

Use according to claim 1 , wherein the compound (B) is defined by the following formula

(lib):

wherein Ri is selected from -H, -CH3, -CH2-CH3, -(CH2)2-CH3, -C(CH3)-CH3, acyl, preferably formyl, acetyl, propionyl, halogenated acyl, like halogenated acetyl, halogenated propionyl, more preferably -CO-CH2CI, -CO-CHCI-CH3, -CO-CH2-CH2CI, R2 is selected from linear or branched Ci to C6 alkyl, preferably methyl, ethyl propyl, butyl, pentyl, hexyl, isopropyl, isobutyl, sec-butyl, tert-butyl, 1 -ethylpropyl, 2-ethylpropyl, and chlorinated and/or hydroxylated derivatives thereof, and methoxylated or

ethoxylated Ci to C6 alkyl, preferably methoxymethyl, 1 -methoxy-ethyl, 2-methoxy-ethyl, 1 -methoxy-1 -propyl, 2-methoxy-1 -propyl, 1 -methoxy-2-propyl, , 2-methoxy-2-propyl, 2- methoxy-3-propyl, 1 -ethoxy-ethyl, 2-ethoxy-ethyl, 1 -ethoxy-1 -propyl, 2-ethoxy-1 -propyl, 1 -ethoxy-2-propyl, 2-ethoxy-2-propyl, 2-ethoxy-3-propyl, and N-(1 H-pyrazol-1 -ylmethyl. R6, R7, Re and R9 are independently selected from linear or branched, saturated or unsaturated, optionally hydroxy-substituted Ci to C6 alkyl, preferably -H, -CH3, -CH2-CH3, -(CH2)2-CH3, -C(CH3)-CH3, -CI, -OH or -N02, Y is selected from aromatic CH, aromatic C(CH3), S, and O, and n is 0 or 1.

Use according to claim 4, wherein the compound (B) is selected from the list of compounds defined by the following formulae (Ilia), (lllb), (lllc), (llld) and combinations thereof:

(Mid).

Use according to one of the preceding claims, wherein the compound (B) has water- solubility of not higher than 50 g/L, preferably not higher than 40 g/L.

Use according to one of the preceding claims, wherein the compound (B) has vapor pressure of less than 1 Pa at ambient temperature.

Use according to one of the preceding claims, wherein the compound (B) is a liquid at standard ambient temperature of 25°C and standard ambient pressure of 100 kPa or an amorphous solid.

Use according to one of the preceding claims, wherein the ratio of (A) clomazone to compound (B) in the formulation for agricultural end use is from 1 :12 to 1 :0.5, preferably 1 :10 to 1 :3, more preferably 1 :7 to 1 :5, based on the weight of the compounds.

10. Use according to one of the preceding claims, wherein the relative amount of compound (B) in the formulation for agricultural end use is not higher than 90 % by weight, preferably not higher than 80 % by weight, more preferably not higher than 70 % by weight, and most preferably not higher than 60 % by weight, based on the total weight of the composition.

Use according to one of the preceding claims, wherein the clomazone

encapsulated clomazone, preferably not encapsulated by a polymer.

Use according to one of the preceding claims, wherein the composition is formulated as an emulsion, an emulsifiable concentrate or a suspension.

Use as defined in one of the preceding claims 1 to 12 for reducing the volatility of clomazone in a herbicidal composition, wherein the reduction in volatility of clomazone in the herbicidal composition is at least 5 %, more preferably 10 %, even more preferably 20 %, even more preferably 30 %, and most preferably 40 %, relative to the volatility of clomazone in the herbicidal composition without compound (B).

Process for the preparation of a composition according to one of the preceding claims 1 to 12 comprising clomazone with reduced volatility including the steps of

providing a compound (A) which is clomazone, and

reducing the volatility of clomazone in said composition by adding to said composition the compound (B).

Description:
Formulation of clomazone having reduced volatility

Field of the invention [0001 ] The present disclosure relates to compositions comprising the herbicide clomazone. Background of the invention

[0002] Clomazone, the common name for 2-(2-chlorophenyl)methyl-4,4-dimethyl-3- isoxazolidinone, is known to have high herbicidal activity. Clomazone inhibits the biosynthesis of carotinoids in plants and prevents plants from synthesizing chlorophyll thereby allowing efficient weed control.

[0003] One important limitation of using clomazone in herbicidal formulations is the high volatility of clomazone. Due to the high volatility of clomazone, the application of clomazone on soil surfaces by common agricultural spray techniques leads to the problem that clomazone may migrate to adjacent areas of the treated soil thereby having the risk of causing undesired plant damage in non-treated areas of the soil. In order to avoid such off-site injury of plants, restrictions for the use of clomazone have been imposed and must be observed in herbicidal control during agricultural production. Such regulatory limitations complicate the application of clomazone in the soil area of interest because herbicidal control must additionally observe weather conditions, spray volumes, the distance to other nearby fields of agricultural production and the like.

[0004] In order to overcome the set-backs arising from the relatively high volatility of clomazone, various attempts have been made in the art to reduce the effective volatility of clomazone in herbicidal compositions.

[0005] Most prominent have been the microencapsulation of clomazone in herbicidal compositions in order to diminish the effective volatility of clomazone in the resulting herbicidal formulation.

[0006] WO 96/14743 A1 suggested herbicidal compositions comprising clomazone in which the volatility of clomazone has been diminished by encapsulating an emulsifiable concentrate of clomazone in a polyurea shell formed from isocyanate and an amine component.

[0007] Similarly, WO 00/10392 A1 describes compositions of clomazone with additional herbicides that have been microencapsulated in an additional coating formed by a polymeric polyurea-shell.

[0008] WO 05/015999 A1 discloses the microencapsulation of combinations of herbicides like metazachlor and clomazone with further herbicides leading to herbicidal formulations with improved storage stability.

[0009] WO 201 1/039172 A2 discloses low volatility salts of anionic pesticides including dicamba which is 3,6-dichloro-2-methoxybenzoic acid, and similar herbicidal compounds.

[00010] Accordingly, there is continued interest to provide herbicidal formulations of clomazone with reduced volatility in order to allow herbicidal treatment of soil in a more straightforward manner while further minimizing the risk of injuring sensitive off-target crops or plants.

Summary of the invention [0001 1 ] The present inventors have surprisingly found that compositions with high herbicidal activity and at the same time with significantly lower volatility of clomazone can be prepared by mixing clomazone, preferably non-encapsulated clomazone, with other nitrogen-containing compounds. In such formulations with clomazone the effective volatility of clomazone is surprisingly reduced by the presence of the second component thereby allowing generating herbicidal, clomazone-based formulations which do not need to rely on the previous

sophisticated encapsulation technologies for clomazone while still having a clomazone component with excellent herbicidal activity and significantly reduced volatility thereby allowing avoiding the complications usually arising from conventional, highly volatile clomazone.

[00012] In addition, those other nitrogen-containing compounds (B) according to the present invention may optionally represent compounds with own herbicidal activity. Accordingly, in some embodiments of the present invention, the claimed herbicidal compositions not only contain a less volatile and therefore more efficient clomazone component but at the same time contain a second additional component with independent herbicidal activity thereby allowing providing herbicidal formulations in which the combined action of different components lead to synergistic herbicidal effects in the treatment of plants and crop.

[00013] The present invention is directed to the use of a compound (B) for reducing the volatility of clomazone in a herbicidal composition, comprising the step of adding the compound (B) to the herbicidal composition comprising clomazone,

wherein compound (B) is defined by the following formula (I)

wherein the substituents R 1 , R 2 , R 3 , R 4 and X are defined as follows:

Ri is selected from hydrogen, linear or branched, saturated or unsaturated, optionally hydroxyl- substituted, alkyl, acyl and halogenated acyl,

R2 is independently selected from linear or branched alkyl, halogenated alkyl, hydroxylated alkyl, alkoxylated alkyl and N-1 H-pyrazol-1 -ylmethyl,

R3 is independently selected from aromatic or non-aromatic C(Rs) with substituent R 5 selected from hydrogen or linear or branched, saturated or unsaturated, optionally hydroxy-substituted Ci to C25 alkyl, C(Rs) preferably being selected from non-aromatic -C(Rs), aromatic CH, aromatic C-CH3, aromatic C-CH2-CH3, aromatic C-(CH 2 )2-CH 3 , aromatic -C-C(CH 3 )-CH 3 ; aromatic C-CI, aromatic C-OH and aromatic C-NO2,

R 4 is independently selected from aromatic CH-CH-CH, aromatic C(CH3)-CH-CH, aromatic CH- C(CH 3 )-CH, aromatic CH-CH-C(CH 3 ), aromatic C(CH 3 )-C(CH 3 )-CH, aromatic C(CH 3 )-CH- C(CH 3 ), aromatic CH-C(CH 3 )-C(CH 3 ), aromatic CH-S, or is absent, and X is independently selected from aromatic CH, aromatic C-CH3, aromatic C-CH2-CH3, aromatic C-(CH2)2-CH3, aromatic C-CI, aromatic C-OH, aromatic C-NO2, O, NH, and S.

[00014] In another preferred embodiment of the present invention, the use as defined above is claimed, wherein the compound (B) is defined by the following formula (I la)

wherein R 1 and R 2 independently represent hydrogen or linear or branched, saturated or unsaturated, optionally hydroxy-substituted Ci to C12 alkyl, preferably methyl, ethyl, propyl or isopropyl and R 3 is non-aromatic CR 5 wherein R 5 is selected from linear or branched, saturated or unsaturated, optionally hydroxy-substituted C5 to C25 alkyl.

[00015] In another preferred embodiment of the present invention, the use as defined above is claimed, wherein the compound according to formula (I la) is selected from the fatty acid amides of capronic acid, caprylic acid, capric acid, lauric acid, myrystic acid, palmitic acid, stearic acid, isostearic acid, 12-hydroxy stearic acid, ricinoleic acid, oleic acid, linoleic acid, linolenic acid, gadoleic acid, arachidonic acid, erucic acid, behenic acid, ciric acid, lactic acid and the mixtures thereof, preferably the dimethyl fatty acid amides and their mixtures thereof.

[00016] In another preferred embodiment of the present invention, the use as defined above is claimed, wherein the compound (B) is defined by the following formula (lib):

wherein Ri is selected from -H, -CH 3 , -CH2-CH3, -(CH 2 )2-CH 3 , -C(CH 3 )-CH 3 , acyl, preferably formyl, acetyl, propionyl, halogenated acyl, like halogenated acetyl, halogenated propionyl, more preferably -CO-CH2CI, -CO-CHCI-CH 3 , -CO-CH 2 -CH 2 CI,

R2 is selected from linear or branched Ci to C6 alkyl, preferably methyl, ethyl propyl, butyl, pentyl, hexyl, isopropyl, isobutyl, sec-butyl, tert-butyl, 1 -ethylpropyl, 2-ethylpropyl, and chlorinated and/or hydroxylated derivatives thereof, and methoxylated or ethoxylated Ci to C6 alkyl, preferably methoxymethyl, 1 -methoxy-ethyl, 2-methoxy-ethyl, 1 -methoxy-1 -propyl, 2- methoxy-1 -propyl, 1 -methoxy-2-propyl, , 2-methoxy-2-propyl, 2-methoxy-3-propyl, 1 -ethoxy- ethyl, 2-ethoxy-ethyl, 1 -ethoxy-1 -propyl, 2-ethoxy-1 -propyl, 1 -ethoxy-2-propyl, 2-ethoxy-2- propyl, 2-ethoxy-3-propyl, and N-(1 H-pyrazol-1 -ylmethyl,

R6, R7, Re and R9 are independently selected from linear or branched, saturated or unsaturated, optionally hydroxy-substituted Ci to C 6 alkyl, preferably -H, -CH 3 , -CH 2 -CH 3 , -(CH 2 ) 2 -CH 3 , - C(CH 3 )-CH 3 , -CI, -OH or -NO2, Y is selected from aromatic CH, aromatic C(CH 3 ), S, and O, and n is 0 or 1 . [00017] In another preferred embodiment of the present invention, the use as defined above is claimed, wherein the compound (B) is selected from the list of compounds defined by the following formulae (Ilia), (1Mb), (Illc), (llld) and combinations thereof:

[00018] In another preferred embodiment of the present invention, the use as defined above is claimed, wherein the compound (B) has water-solubility of not higher than 50 g/L, preferably not higher than 40 g/L.

[00019] In another preferred embodiment of the present invention, the use as defined above is claimed, wherein the compound (B) has vapor pressure of less than 1 Pa at ambient temperature. [00020] In another preferred embodiment of the present invention, the use as defined above is claimed, wherein the compound (B) is a liquid at standard ambient temperature of 25°C and standard ambient pressure of 100 kPa or an amorphous solid.

[00021 ] In another preferred embodiment of the present invention, the use as defined above is claimed, wherein the ratio of (A) clomazone to compound (B) in the formulation for agricultural end use is from 1 :12 to 1 :0.5, preferably 1 :10 to 1 :3, more preferably 1 :7 to 1 :5, based on the weight of the compounds.

[00022] In another preferred embodiment of the present invention, the use as defined above is claimed, wherein the relative amount of compound (B) in the formulation for agricultural end use is not higher than 90 % by weight, preferably not higher than 80 % by weight, more preferably not higher than 70 % by weight, and most preferably not higher than 60 % by weight, based on the total weight of the composition.

[00023] In another preferred embodiment of the present invention, the use as defined above is claimed, wherein the clomazone is a non-encapsulated clomazone, preferably not

encapsulated by a polymer.

[00024] In another preferred embodiment of the present invention, the use as defined above is claimed, wherein the composition is formulated as an emulsion, an emulsifiable concentrate or a suspension.

[00025] In another preferred embodiment of the present invention, the use as defined above is claimed for reducing the volatility of clomazone in a herbicidal composition, wherein the reduction in volatility of clomazone in the herbicidal composition is at least 5 %, more preferably 10 %, even more preferably 20 %, even more preferably 30 %, and most preferably 40 %, relative to the volatility of clomazone in the herbicidal composition without compound (B).

[00026] In another preferred embodiment of the present invention, a process is claimed for the preparation of a composition according to one of the preceding claims 1 to 12 comprising clomazone with reduced volatility including the steps of providing a compound (A) which is clomazone, and reducing the volatility of clomazone in said composition by adding to said composition the compound (B). Brief Description of the Drawings

[00027] Fig. 1 : Influence of the presence of dimethenamid in herbicidal compositions on the volatility of clomazone.

[00028] Fig. 2: Influence of the presence of dimethyl fatty acid amides in herbicidal compositions on the volatility of clomazone.

[00029] Fig. 3: Influence of the carbon chain length of dimethyl fatty acid amides in herbicidal compositions on the volatility of clomazone.

[00030] Fig. 4: Influence of standing time of herbicidal compositions on the volatility of clomazone. Detailed Description

[00031 ] The composition according to the present invention comprises a mixture of a compound (A) which is a clomazone component selected from clomazone and/or a derivative of clomazone which also has herbicidal activity. Clomazone is a well-established herbicidal compound with the chemical structure 2-[(2-chlorophenyl)methyl]-4,4-dimethyl-3- isoxazolidinone.

[00032] Preferably, the clomazone component (A) is non-encapsulated, i.e. clomazone is not contained in an encapsulated form in the compositions according to the present invention. The volatility of clomazone in herbicidal compositions has been traditionally limited by encapsulating clomazone using a polymeric shell, e.g. a polyurethane or polyurea coating, in order to reduce the effective volatility of clomazone in the herbicidal composition. Such a coating, preferably polymeric coating, for the clomazone component (A) is preferably not present in the

compositions according to the present invention.

[00033] As another component, the composition according to the present invention further comprises a compound (B) which is defined by the following formula (I).

wherein wherein the substituents R 1 , R 2 , R 3 , R 4 and X are defined as follows:

Ri is selected from hydrogen, linear or branched, saturated or unsaturated, optionally hydroxyl- substituted, alkyi, acyl and halogenated acyl,

R2 is independently selected from linear or branched alkyi, halogenated alkyi, hydroxylated alkyi and alkoxylated alkyi, and N-1 H-pyrazol-1 -ylmethyl,

R3 is independently selected from aromatic C(Rs) with substituent R 5 selected from hydrogen or linear or branched, saturated or unsaturated, optionally hydroxy-substituted Ci to C25 alkyi, preferably aromatic CH, aromatic C-CH3, aromatic C-CH2-CH3, aromatic C-(CH2)2-CH3, aromatic C-C(CH 3 )-CH 3 ; aromatic C-CI, aromatic C-OH or aromatic C-NO2,

R 4 is independently selected from aromatic CH-CH-CH, aromatic C(CH3)-CH-CH, aromatic CH- C(CH 3 )-CH, aromatic CH-CH-C(CH 3 ), aromatic C(CH 3 )-C(CH 3 )-CH, aromatic C(CH 3 )-CH- C(CH 3 ), aromatic CH-C(CH 3 )-C(CH 3 ), aromatic CH-S , aromatic CH-O, or is absent, and X is independently selected from aromatic CH, aromatic C-CH3, aromatic C-CH2-CH3, aromatic C- (CH 2 )2-CH 3 , aromatic C-CI, aromatic C-OH, aromatic C-NO2, O, NH, and S. Propenyl- substituted acetamide derivatives, like for instance pethoxamid, do not fall under the scope defined by formula (I) and are therefore not encompassed by the compound (B) according to formula (I).

[00034] In one first main preferred embodiment, the compound (B) according to formula (I) preferably is defined by a fatty acid amide according to the following formula (I la) (Ma) wherein R 1 and R 2 independently represent hydrogen or linear or branched, saturated or unsaturated, optionally hydroxy-substituted Ci to C12 alkyl, preferably methyl, ethyl, propyl or isopropyl, and R 3 is non-aromatic CR 5 wherein R 5 is selected from linear or branched, saturated or unsaturated, optionally hydroxy-substituted C5 to C25 alkyl.

[00035] More preferred fatty acid amides according to formula (I I a) are those in which R 3 -CO stands for a linear or branched, saturated or unsaturated, optionally hydroxyl- substituted acyl radical having 2 to 25 carbon atoms and 0 or 1 to 3 double bonds, and R 1 and R 2 independently represent either hydrogen or alkyl radicals having 1 to 12 carbon atoms.

[00036] Very preferred fatty acid amides according to the present invention include the amides derived from the following carboxylic acids: capronic acid, caprylic acid, capric acid, lauric acid, myrystic acid, palmitic acid, stearic acid, isostearic acid, 12-hydroxy stearic acid, ricinoleic acid, oleic acid, linoleic acid, linolenic acid, gadoleic acid, arachidonic acid, erucic acid, behenic acid and their mixtures. Also suitable are amides derived from hydroxy acids, like citric acid or in particular lactic acid.

[00037] The most preferred fatty acid amides according to the present invention are derived from the above fatty acids and are fatty acid dialkyl amides, wherein R 1 and R 2 independently represent methyl, ethyl, propyl, isopropyl or combinations thereof. Most preferred are the fatty acid dimethyl amides, like the C6-C10 fatty acid dimethyl amides, as for example Agnique® KE 3658 (Cognis GmbH).

[00038] The fatty acid amides can be present in the formulation for agricultural end use in amounts of from 10 to about 90 % per weight, preferably from 20 to 80 % by weight, more preferably from 30 to 70 % by weight, and even more preferably from 40 to 60 % by weight based on the total composition.

[00039] In a second main preferred embodiment of the present invention, the compound (B) according to formula (I) preferably is defined by a compound according to the following formula (lib):

wherein Ri is selected from -H, -CH 3 , -CH2-CH3, -(CH 2 )2-CH 3 , -C(CH 3 )-CH 3 , acyl, like formyl, acetyl, propionyl, halogenated acyl, like halogenated acetyl, halogenated propionyl, preferably CO-CH2CI, -CO-CHCI-CH3, -CO-CH2-CH2CI,

R2 is selected from linear or branched Ci to C6 alkyl, preferably methyl, ethyl propyl, butyl, pentyl, hexyl, isopropyl, isobutyl, sec-butyl, tert-butyl, 1 -ethylpropyl, 2-ethylpropyl, and chlorinated and/or hydroxylated derivatives thereof, and methoxylated or ethoxylated Ci to C6 alkyl, preferably methoxymethyl, 1 -methoxy-ethyl, 2-methoxy-ethyl, 1 -methoxy-1 -propyl, 2- methoxy-1 -propyl, 1 -methoxy-2-propyl, , 2-methoxy-2-propyl, 2-methoxy-3-propyl, 1 -ethoxy- ethyl, 2-ethoxy-ethyl, 1 -ethoxy-1 -propyl, 2-ethoxy-1 -propyl, 1 -ethoxy-2-propyl, , 2-ethoxy-2- propyl, 2-ethoxy-3-propyl, and N-(1 H-pyrazol-1 -ylmethyl,

R6, R7, Re and R9 are independently selected from linear or branched, saturated or unsaturated, optionally hydroxy-substituted Ci to C 6 alkyl, preferably -H, -CH 3 , -CH2-CH3, -(CH 2 )2-CH 3 , - C(CH 3 )-CH 3 , -CI, -OH or -NC-2,

Y is selected from aromatic CH, aromatic C(CH3), S, and O, and n is 0 or 1.

[00040] The compound (B) according to formula (lib) can be present in the formulation for agricultural end use in amounts of from 20 to about 95 % per weight, preferably from 30 to 85 % by weight, more preferably from 40 to 75, even more preferably from 50 to 70 % by weight based on the total composition.

[00041 ] One very preferred compound (B) according to formula (lib) is the known herbicide dimethenamid (R,S-2-Chloro-/S/-(2,4-dimethyl-3-thienyl)-A/-(2-methoxy-1 -methylethyl)acetamide which has the following formula (Ilia):

[00042] Dimethenamid can be used in the present invention as the mixture of the R -isomer and the S-isomer in a certain ratio, preferably as the racemate of the R -isomer and the S- isomer in equal amounts or, alternatively, dimethenamid can be used in the present invention as the S-isomer, commonly called dimethenamid P, which essentially is free of the R-isomer. Dimethenamid is a commercially available herbicide compound.

[00043] Another very preferred compound (B) according to formula (lib) is the herbicidal compound pendimethalin having the chemical structure according to the following formula (1Mb).

3 3 (1Mb)

[00044] Pendimethalin has the correct chemical name N-(1 -ethylpropyl)-3,4-dimethyl-2,6- dinitrophenylamine or sometimes alternatively called 3,4-Dimethyl-2,6-dinitro-A/-pentan-3-yl- aniline and is also commercially available.

[00045] Another very preferred compound (B) according to formula (lib) is the herbicidal compound metolachlor having the chemical structure according to the following formula (I lie).

[00046] Metolachlor has the correct chemical name (RS)-2-ethyl-6-methyl-N-(1 '-methyl-2'- methoxyethyl)-chloracetanilid. The present invention comprises the isolated stereoisomers of metolarchlor or mixtures, preferably the racemic mixtures, thereof.

[00047] Another very preferred compound (B) according to formula (lib) is the herbicidal compound metazachlor having the chemical structure according to the following formula (Illd).

[00048] Metazachlor has the correct chemical name (RS)-2-chloro-A/-(2,6-dimethylphenyl)- N-(1 H-pyrazole-1 -ylmethyl)acetamide. The present invention includes the two atropisomers compounds of metazachlor and the optical isomers thereof, either in isolated form or as the corresponding mixtures thereof.

[00049] In an alternative embodiment of the present invention, 2-component mixtures, 3- component mixtures or the 4-component mixture of pendimethalin, dimethenamid, metolachlor and metazachlor can be used as component (B) in the compositions according to the present invention.

[00050] The compound (B) according to the present invention has only limited water solubility. The water solubility of the compound (B) is not higher than 80 g/L, preferably not higher than 50 g/L, and most preferably not higher than 40 g/l.

[00051 ] Some very preferred compounds (B) according to the present invention even are essentially not soluble in water at all having water solubility which is even much lower than the values mentioned above. Accordingly, some selected, very preferred embodiments for compound (B) have very limited water solubility, or water miscibility, of not higher than 1 g/L, preferably not higher than 0.1 g/L, or even more preferably not higher than 0.01 g/L at room temperature.

[00052] One important characteristic of the compound (B) according to the present invention is the vapor pressure since the vapor pressure of a certain compound influences the effective volatility of the compound.

[00053] The compound (B) according to the present invention has a vapor pressure which is preferably not higher than 20 mPa at room temperature, preferably not higher than 10 mPa, more preferably not higher than 5 mPa, and most preferably not higher than 1 mPa. [00054] The compound (B) according to the present invention is preferably in a liquid state at room temperature or, when being solid at room temperature, in amorphous form. The compound (B) can also be dissolved in an appropriate solvent. The compound (B) of the present invention is most preferably not in a crystalline state at room temperature.

[00055] In the herbicidal compositions according to the present invention, the ratio of (A) clomazone to compound (B) is from 1 :12 to 1 :0.5, preferably 1 :10 to 1 :3, more preferably 1 :7 to 1 :5, based on the weight of the compounds.

[00056] The relative amount of compound (B) in the composition according to the present invention the relative amount of compound (B) in the composition is not higher than 90 % by weight, preferably not higher than 80 % by weight, more preferably not higher than 70 % by weight, and most preferably not higher than 60 % by weight, based on the total weight of the composition. Especially preferred is a relative amount of compound (B) in the composition in the range of 20 to 70 % by weight, or most preferably 30 to 60 % by weight, based on the total weight of the composition.

[00057] The herbicidal compositions according to the present invention can contain, in addition to the herbicidal compound clomazone, additional pesticides. The additional pesticides can be selected from herbicides other than clomazone itself, fungicides, biological, insecticides, inoculants, nutrients, surfactants, wetting agents, and mixtures thereof.

[00058] Preferred herbicides in addition to clomazone to be used in the process according to the present invention include the following substances and mixtures thereof:

acetamides: acetochlor, alachlor, butachlor, dimethachlor, flufenacet, mefenacet, napropamide, naproanilide, pethoxamid, pretilachlor, propachlor, thenylchlor;

amino acid derivatives: bilanafos, glyphosate, glufosinate, sulfosate;

- aryloxyphenoxypropionat.es: clodinafop, cyhalofop-butyl, fenoxaprop, fluazifop,

haloxyfop, metamifop, propaquizafop, quizalofop, quizalofop-P-tefuryl;

- bipyridyls: diquat, paraquat;

- (thio)carbamates: asulam, butylate, carbetamide, desmedipham, dimepiperate, eptam (EPTC), esprocarb, molinate, orbencarb, phenmedipham, prosulfocarb, pyributicarb, thiobencarb, triallate;

- cyclohexanediones: butroxydim, clethodim, cycloxydim, profoxydim, sethoxydim,

tepraloxydim, tralkoxydim;

dinitroanilines: benfluralin, ethalfluralin, oryzalin, prodiamine, trifluralin;

diphenyl ethers: acifluorfen, aclonifen, bifenox, diclofop, ethoxyfen, fomesafen, lactofen, oxyfluorfen;

- hydroxybenzonitriles: bomoxynil, dichlobenil, ioxynil;

imidazolinones: imazamethabenz, imazamox, imazapic, imazapyr, imazaquin, imazethapyr;

- phenoxy acetic acids: clomeprop, 2,4-dichlorophenoxyacetic acid (2,4-D), 2,4-DB,

dichlorprop, MCPA, MCPA-thioethyl, MCPB, Mecoprop;

- pyrazines: chloridazon, flufenpyr-ethyl, fluthiacet, norflurazon, pyridate; pyridines:

aminopyralid, clopyralid, diflufenican, dithiopyr, fluridone, fluroxypyr, picloram, picolinafen, thiazopyr;

sulfonyl ureas: amidosulfuron, azimsulfuron, bensulfuron, chlorimuron-ethyl,

chlorsulfuron, cinosulfuron, cyclosulfamuron, ethoxysulfuron, flazasulfuron, flucetosulfuron, flupyrsulfuron, foramsulfuron, halosulfuron, imazosulfuron, iodosulfuron, mesosulfuron, metazosulfuron, metsulfuron-methyl, nicosulfuron, oxasulfuron, primisulfuron, prosulfuron, pyrazosulfuron, rimsulfuron, sulfometuron, sulfosulfuron, thifensulfuron, triasulfuron, tribenuron, trifloxysulfuron, triflusulfuron, tritosulfuron, 1 -((2- chloro-6-propyl-imidazo[1 ,2-b]pyridazin-3-yl)sulfonyl)-3-(4,6-dimethoxy-pyrimidin-2 yl)urea;

- triazines: ametryn, atrazine, cyanazine, dimethametryn, ethiozin, hexazinone,

metamitron, metribuzin, prometryn, simazine, terbuthylazine, terbutryn, triaziflam;

ureas: chlorotoluron, daimuron, diuron, fluometuron, isoproturon, linuron,

methabenzthiazuron, tebuthiuron;

other acetolactate synthase inhibitors: bispyribac-sodium, cloransulam-methyl, diclosulam, florasulam, flucarbazone, flumetsulam, metosulam, ortho-sulfamuron, penoxsulam, propoxycarbazone, pyribambenz-propyl, pyribenzoxim, pyriftalid, pyriminobac-methyl, pyrimisulfan, pyrithiobac, pyroxasulfone, pyroxsulam;

- others: amicarbazone, aminotriazole, anilofos, beflubutamid, benazolin, bencarbazone, benfluresate, benzofenap, bentazone, benzobicyclon, bicyclopyrone, bromacil, bromobutide, butafenacil, butamifos, cafenstrole, carfentrazone, cinidon-ethyl, chlorthal,, cumyluron, cyprosulfamide, dicamba, difenzoquat, diflufenzopyr, Drechslera monoceras, endothal, ethofumesate, etobenzanid, fenoxasulfone, fentrazamide, flumiclorac-pentyl, flumioxazin, flupoxam, flurochloridone, flurtamone, indanofan, isoxaben, isoxaflutole, lenacil, propanil, propyzamide, quinclorac, quinmerac , mesotrione, methyl arsonic acid, naptalam, oxadiargyl, oxadiazon, oxaziclomefone, pentoxazone, pinoxaden, pyraclonil, pyraflufen-ethyl, pyrasulfotole, pyrazoxyfen, pyrazolynate, quinoclamine, saflufenacil, sulcotrione, sulfentrazone, terbacil, tefuryltrione, tembotrione, thiencarbazone, topramezone, (3-[2-chloro-4- fluoro-5-(3-methyl-2,6-dioxo-4-trifluoromethyl-3,6-dihydro-

2H-pyrimidin-1 -yl)- phenoxy]-pyridin-2-yloxy)-acetic acid ethyl ester, 6-amino-5-chloro-2- cyclopropyl- pyrimidine-4-carboxylic acid methyl ester, 6-chloro-3-(2-cyclopropyl-6- methyl- phenoxy)-pyridazin-4-ol, 4-amino-3-chloro-6-(4-chloro-phenyl)-5-fluoro-pyridine- 2- carboxylic acid, 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxy-phenyl)-pyri dine- 2- carboxylic acid methyl ester, and 4-amino-3-chloro-6-(4-chloro-3-dimethylamino- 2- fluoro-phenyl)-pyridine-2-carboxylic acid methyl ester.

[00059] The herbicide is present in the composition for agricultural end use in an amount of 0.0001 to 0.1 % by weight, preferably 0.0005 to 0.05 % by weight, and even more preferably 0.001 to 0.01 % by weight based on the total composition.

[00060] Preferred insecticides to be used in the process according to the present invention include the following substances and mixtures thereof:

- organo(thio)phosphates: acephate, azamethiphos, azinphos-methyl, chlorpyrifos,

chlorpyrifos-methyl, chlorfenvinphos, diazinon, dichlorvos, dicrotophos, dimethoate, disulfoton, ethion, fenitrothion, fenthion, isoxathion, malathion, methamidophos, methidathion, methyl-parathion, mevinphos, monocrotophos, oxydemeton-methyl, paraoxon, parathion, phenthoate, phosalone, phosmet, phosphamidon, phorate, phoxim, pirimiphos-methyl, profenofos, prothiofos, sulprophos, tetrachlorvinphos, terbufos, triazophos, trichlorfon;

- carbamates: alanycarb, aldicarb, bendiocarb, benfuracarb, carbaryl, carbofuran, carbosulfan, fenoxycarb, furathiocarb, methiocarb, methomyl, oxamyl, pirimicarb, propoxur, thiodicarb, triazamate;

- pyrethroids: allethrin, bifenthrin, cyfluthrin, cyhalothrin, cyphenothrin, cypermethrin,

alpha-cypermethrin, beta-cypermethrin, zeta-cypermethrin, deltamethrin, esfenvalerate, etofenprox, fenpropathrin, fenvalerate, imiprothrin, lambda-cyhalothrin, permethrin, prallethrin, pyrethrin I and II, resmethrin, silafluofen, tau-fluvalinate, tefluthrin, tetramethrin, tralomethrin, transfluthrin, profluthrin, dimefluthrin;

- insect growth regulators: a) chitin synthesis inhibitors: benzoylureas: chlorfluazuron, cyramazin, diflubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, teflubenzuron, triflumuron; buprofezin, diofenolan, hexythiazox, etoxazole, clofentazine; b) ecdysone antagonists: halofenozide, methoxyfenozide, tebufenozide, azadirachtin; c) juvenoids: pyriproxyfen, methoprene, fenoxycarb; d) lipid biosynthesis inhibitors: spirodiclofen, spiromesifen, spirotetramat;

- nicotinic receptor agonists/antagonists compounds: clothianidin, dinotefuran,

flupyradifurone, imidacloprid, thiamethoxam, nitenpyram, acetamiprid, thiacloprid, 1 -2- chloro-thiazol-5-ylmethyl)-2-nitrimino-3,5-dimethyl-[1 ,3,5]triazinane;

- GABA antagonist compounds: endosulfan, ethiprole, fipronil, vaniliprole, pyrafluprole, pyriprole, 5-amino-1 -(2,6-dichloro-4-methyl-phenyl)-4-sulfinamoyl-1 H-pyrazole-3- carbothioic acid amide;

- macrocyclic lactone insecticides: abamectin, emamectin, milbemectin, lepimectin,

spinosad, spinetoram;

- mitochondrial electron transport inhibitor (METI) I acaricides: fenazaquin, pyridaben, tebufenpyrad, tolfenpyrad, flufenerim;

- METI II and III compounds: acequinocyl, fluacyprim, hydramethylnon;

- Uncouplers: chlorfenapyr;

- oxidative phosphorylation inhibitors: cyhexatin, diafenthiuron, fenbutatin oxide,

propargite;

- moulting disruptor compounds: cryomazine;

- mixed function oxidase inhibitors: piperonyl butoxide;

- sodium channel blockers: indoxacarb, metaflumizone;

- ryanodine receptor inhibitors: chlorantraniliprole, cyantraniliprole, flubendiamide, N-[4,6- dichloro-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-pheny l]-2-(3-chloro-2-pyridyl)-5- (trifluoromethyl)pyrazole-3-carboxamide; N-[4-chloro-2-[(diethyl-lambda-4- sulfanylidene)carbamoyl]-6-methyl-phenyl]-2-(3-chloro-2-pyri dyl)-5-(triflu- oromethyl)pyrazole-3-carboxamide; N-[4-chloro-2-[(di-2-propyl-lambda-4-sulfanyli- dene)carbamoyl]-6-methyl-phenyl]-2-(3-chloro-2-pyridyl)-5-(t rifluoromethyl)pyrazole-3- carboxamide; N-[4,6-dichloro-2-[(di-2-propyl-lambda-4-sulfanylidene)carba moyl]-phenyl]- 2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxa mide; N-[4,6-dichloro-2- [(diethyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chl oro-2-pyridyl)-5-(di- fluoromethyl)pyrazole-3-carboxamide; N-[4,6-dibromo-2-[(di-2-propyl-lambda-4-sul- fanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trif luoromethyl)pyrazole-3- carboxamide; N-[4-chloro-2-[(di-2-propyl-lambda-4-sulfanylidene)carbamoyl ]-6-cyano- phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3 -carboxamide; N-[4,6-dibromo- 2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-c hloro-2-pyridyl)-5-(tri- fluoromethyl)pyrazole-3-carboxamide; cyazypyr, rynaxapyr;

- others: benclothiaz, bifenazate, artap, flonicamid, pyridalyl, pymetrozine, sulfur,

thiocyclam, cyenopyrafen, flupyrazofos, cyflumetofen, amidoflumet, imicyafos, bistrifluron, pyrifluquinazon and 1 ,1 '-[(3S,4R,4aR,6S,6aS,12R,12aS,12bS)-4-[[(2- cyclopropylacetyl)oxy]methyl]-1 ,3,4,4a,5,6,6a,12,12a,12b-decahydro-12-hydroxy-

4,6a,12b-trimethyl-1 1 -oxo-9-(3-pyridinyl)-2H,1 1 H-naphtho[2,1 -b]pyrano[3,4-e]pyran-3,6- diyl] cyclopropaneacetic acid ester

[00061 ] Even more preferred insecticides to be used in the process according to the present invention include the following substances and mixtures thereof:

- carbamates: methiocarb, thiodicarb;

- pyrethroids: bifenthrin, cypermethrin, alpha-cypermethrin, beta-cypermethrin, zeta- cypermethrin, deltamethrin, tefluthrin;

- nicotinic receptor agonists/antagonists compounds: clothianidin, dinotefuran,

imidacloprid, thiamethoxam, acetamiprid, thiacloprid;

- GABA antagonist compounds: fipronil;

- ryanodine receptor inhibitors: cyazypyr, rynaxapyr

[00062] The most preferred insecticides to be used in the process according to the present invention include the following substances and mixtures thereof:

- carbamates: methiocarb, thiodicarb;

- pyrethroids: bifenthrin, cypermethrin, alpha-cypermethrin, beta-cypermethrin, zeta- cypermethrin, deltamethrin, tefluthrin;

- nicotinic receptor agonists/antagonists compounds: clothianidin, dinotefuran,

imidacloprid, thiamethoxam, acetamiprid, thiacloprid;

- GABA antagonist compounds: fipronil;

- ryanodine receptor inhibitors: cyazypyr, rynaxapyr.

[00063] The insecticide is present in the compositions for agricultural end use in an amount of 0.0001 to 0.1 % by weight, preferably 0.0005 to 0.01 % by weight, and even more preferably 0.001 to 0.006 % by weight based on the total composition.

[00064] Preferred fungicides to be used in the process according to the present invention include the following substances and mixtures thereof:

A) Respiration inhibitors:

- inhibitors of complex III at Q 0 site (e. g. strobilurins): azoxystrobin, coumethoxystrobin, coumoxystrobin, dimoxystrobin, enestroburin, fenaminstrobin, fenoxy- strobin/flufenoxystrobin, fluoxastrobin, kresoxim-methyl, mandestrobine, meto- minostrobin, orysastrobin, picoxystrobin, pyraclostrobin, pyrametostrobin,

pyraoxystrobin, trifloxystrobin and 2-(2-(3-(2,6-dichlorophenyl)-1 -methyl-allylidene- aminooxymethyl)-phenyl)-2-methoxyimino-N-methyl-acetamide, pyribencarb, triclopyricarb/chlorodincarb, famoxadone, fenamidone;

- inhibitors of complex III at Q, site: cyazofamid, amisulbrom, [(3S,6S,7R,8R)-8-benzyl-3- [(3-acetoxy-4-methoxy-pyridine-2-carbonyl)amino]-6-methyl-4, 9-dioxo-1 ,5-dioxonan-7- yl] 2-methylpropanoate, [(3S,6S,7R,8R)-8-benzyl-3-[[3-(acetoxymethoxy)-4-methoxy- pyridine-2-carbonyl]amino]-6-methyl-4,9-dioxo-1 ,5-dioxonan-7-yl] 2-methylpropanoate, [(3S,6S,7R,8R)-8-benzyl-3-[(3-isobutoxycarbonyloxy-4-methoxy -pyridine- 2-carbonyl)amino]-6-methyl-4,9-dioxo-1 ,5-dioxonan-7-yl] 2-methylpropanoate, [(3S,6S7R,8R)-8-benzyl-3-[[3-(1 ,3-benzodioxol-5-ylmethoxy)-4-methoxy-pyridine-2- carbonyl]amino]-6-methyl-4,9-dioxo-1 ,5-dioxonan-7-yl] 2-methylpropanoate;

(3S,6S7R,8R)-3-[[(3-hydroxy-4-methoxy-2-pyndinyl)carbonyl]am ino]-6-methyl-4,9- dioxo-8-(phenylmethyl)-1 ,5-dioxonan-7-yl 2-methylpropanoate

- inhibitors of complex II (e. g. carboxamides): benodanil, benzovindiflupyr, bixafen, boscalid, carboxin, fenfuram, fluopyram, flutolanil, fluxapyroxad, furametpyr, isofetamid, isopyrazam, mepronil, oxycarboxin, penflufen, penthiopyrad, sedaxane, tecloftalam, thifluzamide, N-(4'-trifluoromethylthiobiphenyl-2-yl)-3-difluoromethyl-1 -methyl- 1 H-pyrazole-4-carboxamide, N-(2-(1 ,3,3-trimethyl-butyl)-phenyl)-1 ,3-dimethyl-5-fluoro- 1 H-pyrazole-4-carboxamide, 3-(difluoromethyl)-1 -methyl-N-(1 ,1 ,3-trimethylindan-4- yl)pyrazole-4-carboxamide, 3-(trifluoromethyl)-1 -methyl-N-(1 ,1 ,3-trimethylindan-4- yl)pyrazole-4-carboxamide, 1 ,3-dimethyl-N-(1 ,1 ,3-trimethylindan-4-yl)pyrazole-4- carboxamide, 3-(trifluoromethyl)-1 ,5-dimethyl-N-(1 ,1 ,3-trimethylindan-4-yl)pyrazole-4- carboxamide, 1 ,3,5-trimethyl-N-(1 ,1 ,3-trimethylindan-4-yl)pyrazole-4-carboxamide, N- (7-fluoro-1 ,1 ,3-trimethyl-indan-4-yl)-1 ,3-dimethyl-pyrazole-4-carboxamide, N-[2-(2,4- dichlorophenyl)-2-methoxy-1 -methyl-ethyl]-3-(difluoromethyl)-1 -methyl-pyrazole-4- carboxamide;

- other respiration inhibitors (e. g. complex I, uncouplers): diflumetorim, (5,8-difluoro- quinazolin-4-yl)-{2-[2-fluoro-4-(4-trifluoromethylpyridin-2- yloxy)-phenyl]-ethyl}-amine; nitrophenyl derivates: binapacryl, dinobuton, dinocap, fluazinam; ferimzone;

organometal compounds: fentin salts, such as fentin-acetate, fentin chloride or fentin hydroxide; ametoctradin; and silthiofam;

Sterol biosynthesis inhibitors (SBI fungicides):

- C14 demethylase inhibitors (DMI fungicides): triazoles: azaconazole, bitertanol,

bromuconazole, cyproconazole, difenoconazole, diniconazole, diniconazole-M, epoxiconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imibenconazole, ipconazole, metconazole, myclobutanil, oxpoconazole,

paclobutrazole, penconazole, propiconazole, prothioconazole, simeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole, uniconazole, 1 -[re/-(2S;3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-oxir anylmethyl]-5-thiocyanato- 1 H-[1 ,2,4]triazole, 2-[re/-(2S;3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-oxi ranyl- methyl]-2H-[1 ,2,4]triazole-3-thiol, 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -(1 ,2,4- triazol-1 -yl)pentan-2-ol, 1 -[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -cyclopropyl- 2-(1 ,2,4-triazol-1 -yl)ethanol, 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -(1 ,2,4- triazol-1 -yl)butan-2-ol, 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1 - yl)butan-2-ol, 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-3-methyl-1 -(1 ,2,4- triazol-1 -yl)butan-2-ol, 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -(1 ,2,4-triazol- 1 -yl)propan-2-ol, 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-3-methyl-1 -(1 ,2,4-triazol-1 - yl)butan-2-ol, 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -(1 ,2,4-triazol-1 - yl)pentan-2-ol, 2-[4-(4-fluorophenoxy)-2-(trifluoromethyl)phenyl]-1 -(1 ,2,4-triazol-1 - yl)propan-2-ol, 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1 -yl)pent-3-yn-2- ol; imidazoles: imazalil, pefurazoate, prochloraz, triflumizol; pyrimidines, pyridines and piperazines: fenarimol, nuarimol, pyrifenox, triforine, [3-(4-chloro-2-fluoro-phenyl)-5- (2,4-difluorophenyl)isoxazol-4-yl]-(3-pyridyl)methanol; - Delta14-reductase inhibitors: aldimorph, dodemorph, dodemorph-acetate,

fenpropimorph, tridemorph, fenpropidin, piperalin, spiroxamine;

- Inhibitors of 3-keto reductase: fenhexamid;

C) Nucleic acid synthesis inhibitors:

- phenylamides or acyl amino acid fungicides: benalaxyl, benalaxyl-M, kiralaxyl,

metalaxyl, metalaxyl-M (mefenoxam), ofurace, oxadixyl;

- others: hymexazole, octhilinone, oxolinic acid, bupirimate, 5-fluorocytosine, 5-fluoro-2- (p-tolylmethoxy)pyrimidin-4-amine, 5-fluoro-2-(4-fluorophenylmethoxy)pyrimidin- 4-amine;

D) Inhibitors of cell division and cytoskeleton:

- tubulin inhibitors, such as benzimidazoles, thiophanates: benomyl, carbendazim, fuberidazole, thiabendazole, thiophanate-methyl; triazolopyrimidines: 5-chloro- 7-(4-methylpiperidin-1 -yl)-6-(2,4,6-trifluorophenyl)-[1 ,2,4]triazolo[1 ,5-a]pyrimidine

- other cell division inhibitors: diethofencarb, ethaboxam, pencycuron, fluopicolide, zoxamide, metrafenone, pyriofenone;

E) Inhibitors of amino acid and protein synthesis:

- methionine synthesis inhibitors (anilino-pyrimidines): cyprodinil, mepanipyrim,

pyrimethanil;

- protein synthesis inhibitors: blasticidin-S, kasugamycin, kasugamycin hydrochloride- hydrate, mildiomycin, streptomycin, oxytetracyclin, polyoxine, validamycin A;

F) Signal transduction inhibitors:

- MAP / histidine kinase inhibitors: fluoroimid, iprodione, procymidone, vinclozolin, fenpiclonil, fludioxonil;

- G protein inhibitors: quinoxyfen;

G) Lipid and membrane synthesis inhibitors:

- Phospholipid biosynthesis inhibitors: edifenphos, iprobenfos, pyrazophos,

isoprothiolane;

- lipid peroxidation: dicloran, quintozene, tecnazene, tolclofos-methyl, biphenyl,

chloroneb, etridiazole;

- phospholipid biosynthesis and cell wall deposition: dimethomorph, flumorph,

mandipropamid, pyrimorph, benthiavalicarb, iprovalicarb, valifenalate and N-(1 -(1 -(4- cyano-phenyl)ethanesulfonyl)-but-2-yl) carbamic acid-(4-fluorophenyl) ester;

- compounds affecting cell membrane permeability and fatty acides: propamocarb, propamocarb-hydrochlorid

- fatty acid amide hydrolase inhibitors: oxathiapiprolin, 2-{3-[2-(1 -{[3,5-bis(difluoromethyl-

1 H-pyrazol-1 -yl]acetyl}piperidin-4-yl)-1 ,3-thiazol-4-yl]-4,5-dihydro-1 ,2-oxazol-5- yl}phenyl methanesulfonate, 2-{3-[2-(1 -{[3,5-bis(difluoromethyl)-1 H-pyrazol-1 - yl]acetyl}piperidin-4-yl) 1 ,3-thiazol-4-yl]-4,5-dihydro-1 ,2-oxazol-5-yl}-3-chlorophenyl methanesulfonate;

H) Inhibitors with Multi Site Action:

- inorganic active substances: Bordeaux mixture, copper acetate, copper hydroxide, copper oxychloride, basic copper sulfate, sulfur;

- thio- and dithiocarbamates: ferbam, mancozeb, maneb, metam, metiram, propineb, thiram, zineb, ziram; - organochlorine compounds (e. g. phthalimides, sulfamides, chloronitriles): anilazine, chlorothalonil, captafol, captan, folpet, dichlofluanid, dichlorophen, hexachlorobenzene, pentachlorphenole and its salts, phthalide, tolylfluanid, N-(4-chloro-2-nitro-phenyl)-N- ethyl-4-methyl-benzenesulfonamide;

- guanidines and others: guanidine, dodine, dodine free base, guazatine, guazatine- acetate, iminoctadine, iminoctadine-triacetate, iminoctadine-tris(albesilate), dithianon, 2,6-dimethyl-1 H,5H-[1 ,4]dithiino[2,3-c:5,6-c']dipyrrole-1 ,3,5,7(2H,6H)-tetraone;

Cell wall synthesis inhibitors:

- inhibitors of glucan synthesis: validamycin, polyoxin B; melanin synthesis inhibitors: pyroquilon, tricyclazole, carpropamid, dicyclomet, fenoxanil;

Plant defence inducers:

- acibenzolar-S-methyl, probenazole, isotianil, tiadinil, prohexadione-calcium;

phosphonates: fosetyl, fosetyl-aluminum, phosphorous acid and its salts;

Unknown mode of action:

- bronopol, chinomethionat, cyflufenamid, cymoxanil, dazomet, debacarb, diclomezine, difenzoquat, difenzoquat-methylsulfate, diphenylamin, fenpyrazamine, flumetover, flusulfamide, flutianil, methasulfocarb, nitrapyrin, nitrothal-isopropyl, oxathiapiprolin, picarbutrazox, tolprocarb, 2-[3,5-bis(difluoromethyl)-1 H-pyrazol-1 -yl]-1 -[4-(4-{5-[2- (prop-2-yn-1 -yloxy)phenyl]-4,5-dihydro-1 ,2-oxazol-3-yl}-1 ,3-thiazol-2-yl)piperidin-1 - yl]ethanone, 2-[3,5-bis(difluoromethyl)-1 H-pyrazol-1 -yl]-1 -[4-(4-{5-[2-fluoro-6-(prop-2- yn-1 -yloxy)phenyl]-4,5-dihydro-1 ,2-oxazol-3-yl}-1 ,3-thiazol-2-yl)piperidin-1 -yl]ethanone,

2- [3,5-bis(difluoromethyl)-1 H-pyrazol-1 -yl]-1 -[4-(4-{5-[2-chloro-6-(prop-2-yn-1 -yl- oxy)phenyl]-4,5-dihydro-1 ,2-oxazol-3-yl}-1 ,3-thiazol-2-yl)piperidin-1 -yl]ethanone, oxin- copper, proquinazid, tebufloquin, tecloftalam, triazoxide, 2-butoxy-6-iodo-

3- propylchromen-4-one, N-(cyclopropylmethoxyimino-(6-difluoro-methoxy-2,3-difluoro- phenyl)-methyl)-2-phenyl acetamide, N'-(4-(4-chloro-3-trifluoromethyl-phenoxy)-2,5- dimethyl-phenyl)-N-ethyl-N-methyl formamidine, N'-(4-(4-fluoro-3-trifluoromethyl- phenoxy)-2,5-dimethyl-phenyl)-N-ethyl-N-methyl formamidine, N'-(2-methyl-5- trifluoromethyl-4-(3-trimethylsilanyl-propoxy)-phenyl)-N-eth yl-N-methyl formamidine, N'- (5-difluoromethyl-2-methyl-4-(3-trimethylsilanyl-propoxy)-ph enyl)-N-ethyl-N-methyl formamidine, methoxy-acetic acid 6-tert-butyl-8-fluoro-2,3-dimethyl-quinolin-4-yl ester, 3-[5-(4-methylphenyl)-2,3-dimethyl-isoxazolidin-3-yl]-pyridi ne, 3-[5-(4-chloro-phenyl)- 2,3-dimethyl-isoxazolidin-3-yl]-pyridine (pyrisoxazole),

N-(6-methoxy-pyridin-3-yl) cyclopropanecarboxylic acid amide, 5-chloro-1 -(4,6-di- methoxy-pyrimidin-2-yl)-2-methyl-1 H-benzoimidazole, 2-(4-chloro-phenyl)- N-[4-(3,4-dimethoxy-phenyl)-isoxazol-5-yl]-2-prop-2-ynyloxy- acetamide, ethyl

(Z)-3-amino-2-cyano-3-phenyl-prop-2-enoate, pentyl N-[6-[[(Z)-[(1 -methyltetrazol-5-yl)- phenyl-methylene]amino]oxymethyl]-2-pyridyl]carbamate, 2-[2-[(7,8-difluoro-2-methyl- 3-quinolyl)oxy]-6-fluoro-phenyl]propan-2-ol, 2-[2-fluoro-6-[(8-fluoro-2-methyl-3- quinolyl)oxy]phenyl]propan-2-ol, 3-(5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin- 1 -yl)quinoline, 3-(4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1 -yl)quinoline, 3- (4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1 -yl)quinolone, 9-fluoro-2,2- dimethyl-5-(3-quinolyl)-3H-1 ,4-benzoxazepine; [00065] Even more preferred fungicides to be used in the process according to the present invention include the following substances and mixtures thereof:

A) Respiration inhibitors:

- Inhibitors of complex III at Q 0 site (e. g. strobilurins): azoxystrobin, picoxystrobin,

pyraclostrobin, trifloxystrobin ;

- inhibitors of complex III at Q, site: cyazofamid;

- inhibitors of complex II (e. g. carboxamides): boscalid, fluopyram, fluxapyroxad,

penflufen, penthiopyrad, sedaxane;

- other respiration inhibitors: fluazinam;

B) Sterol biosynthesis inhibitors (SBI fungicides):

- C14 demethylase inhibitors (DMI fungicides): cyproconazole, difenoconazole, flutriafol, ipconazole, prothioconazole, tebuconazole, triticonazole, prochloraz;

- Delta14-reductase inhibitors: fenpropimorph;

C) Nucleic acid synthesis inhibitors:

- phenylamides or acyl amino acid fungicides: metalaxyl, metalaxyl-M (mefenoxam), ofurace, oxadixyl;

- 5-fluoro-2-(4-fluorophenylmethoxy)pyrimidin-4-amine;

D) Inhibitors of cell division and cytoskeleton:

- tubulin inhibitors, such as benzimidazoles, thiophanates: carbendazim, thiabendazole; - other cell division inhibitors: diethofencarb, ethaboxam, fluopicolide, zoxamide,

metrafenone;

F) Signal transduction inhibitors:

- MAP / histidine kinase inhibitors: fludioxonil;

- G protein inhibitors: quinoxyfen;

G) Lipid and membrane synthesis inhibitors:

- phospholipid biosynthesis and cell wall deposition: dimethomorph, mandipropamid;

- fatty acid amide hydrolase inhibitors: oxathiapiprolin;

H) Inhibitors with Multi Site Action:

- thio- and dithiocarbamates:, mancozeb, maneb, metam, metiram, thiram, ziram;

- organochlorine compounds (e. g. phthalimides, sulfamides, chloronitriles): anilazine, chlorothalonil;

K) Unknown mode of action:

- cyflufenamid, dazomet, nitrapyrin, oxathiapiprolin;

[00066] The most preferred fungicides to be used in the process according to the present invention include the following substances and mixtures thereof:

A) Respiration inhibitors:

- Inhibitors of complex III at Q 0 site (e. g. strobilurins): azoxystrobin, pyraclostrobin, trifloxystrobin;

- inhibitors of complex II (e. g. carboxamides): boscalid, fluopyram, fluxapyroxad,

penflufen, penthiopyrad, sedaxane;

B) Sterol biosynthesis inhibitors (SBI fungicides):

- C14 demethylase inhibitors (DMI fungicides): difenoconazole, ipconazole, prothioconazole, triticonazole;

C) Nucleic acid synthesis inhibitors: - phenylamides or acyl amino acid fungicides: metalaxyl, metalaxyl-M (mefenoxam); D) Inhibitors of cell division and cytoskeleton:

- tubulin inhibitors, such as thiabendazole;

- other cell division inhibitors: ethaboxam;

G) Lipid and membrane synthesis inhibitors:

- fatty acid amide hydrolase inhibitors: oxathiapiprolin;

H) Inhibitors with Multi Site Action:

- thio- and dithiocarbamates:, mancozeb;

- organochlorine compounds (e. g. phthalimides, sulfamides, chloronitriles):

chlorothalonil;

K) Unknown mode of action:

- nitrapyrin, oxathiapiprolin.

[00067] The fungicide is present in the formulation for agricultural end use, in an amount of 0.0001 to 0.1 % by weight, preferably 0.0005 to 0.05 % by weight, and even more preferably 0.001 to 0.01 % by weight based on the total weight of the formulation.

[00068] Preferred inoculants or inoculant compositions according to the present invention comprise microorganisms which have a beneficial effect on plants, preferably the growth of plants. Preferred inoculants to be used in the process according to the present invention include compositions comprising the following microorganisms and combinations thereof:

[00069] Bacteria of the genera Rhizobium, Bradyrhizobium, Sinorhizobium, Mesorhizobium, Pseudomonas, Serratia, Bacillus, Paenibacillus, Pasteuria, Azotobacter, Enterobacter,

Azospirillum, Methylobacterium, Cyanobacteria (blue-green algae), and mycorrhizal fungae.

[00070] Preferred biologicals to be used in the process according to the present invention include the following substances and mixtures thereof:

[00071 ] aluminium silicate (Screen™ Duo from Certis LLC, USA),

[00072] Agrobacterium radiobacter K1026 (e. g. NoGall® from BASF Agricultural

Specialties Pty Ltd, Australia), A. radiobacter K84 (Nature 280, 697-699, 1979; e. g. GallTroll® from AG Biochem, Inc., C, USA), Ampelomyces quisqualis M-10 (e. g. AQ 10® from Intrachem Bio GmbH & Co. KG, Germany), Ascophyllum nodosum (Norwegian kelp, Brown kelp) extract or filtrate (e. g. ORKA GOLD from BASF Agricultural Specialities (Pty) Ltd., South Africa; or

Goemar® from Laboratoires Goemar, France), Aspergillus flavus NRRL 21882 isolated from a peanut in Georgia in 1991 by USDA, National Peanut Research Laboratory (e. g. in Afla- Guard® from Syngenta, CH), mixtures of Aureobasidium pullulans DSM 14940 and DSM 14941 (e. g. blastospores in Blossom Protect® from bio-ferm GmbH, Germany),

[00073] Azospirillum amazonense BR 1 1 140 (SpY2T) (Proc. 9th Int. and 1 st Latin American PGPR meeting, Quimara, Medellin, Colombia 2012, p. 60, ISBN 978-958-46-0908-3), A.

brasilense AZ39 (Eur. J. Soil Biol 45(1 ), 28-35, 2009), A. brasilense XOH (e. g. AZOS from Xtreme Gardening, USA or RTI Reforestation Technologies International; USA), A. brasilense BR 1 1002 (Proc. 9th Int. and 1 st Latin American PGPR meeting, Quimara, Medellin, Colombia 2012, p. 60, ISBN 978-958-46-0908-3), A. brasilense BR 1 1005 (SP245; e. g. in GELFIX

Gramineas from BASF Agricultural Specialties Ltd., Brazil), A. brasilense strains Ab-V5 and Ab- V6 (e. g. in AzoMax from Novozymes BioAg Produtos papra Agricultura Ltda., Quattro Barras, Brazil or SimbioseMaiz® from Simbiose-Agro, Cruz Alta, RS, Brazil; Plant Soil 331 , 413-425, 2010), A. lipoferum BR 1 1646 (Sp31 ) (Proc. 9th Int. and 1 st Latin American PGPR meeting, Quimara, Medellin, Colombia 2012, p. 60),

[00074] Bacillus amyloliquefaciens FZB42 (e. g. in RhizoVital® 42 from AbiTEP GmbH, Berlin, Germany), B. amyloliquefaciens IN937a (J. Microbiol. Biotechnol. 17(2), 280-286, 2007; e. g. in BioYield® from Gustafson LLC, TX, USA), B. amyloliquefaciens IT-45 (CNCM I 3800) (e. g. Rhizocell C from ITHEC, France), B. amyloliquefaciens TJ1000 (also called 1 BE; ATCC BAA- 390; e.g. QuickRoots™ from TJ Technologies, Watertown, SD, USA; CA 2471555 A1 ), B.

amylolique-"faciens ssp. plantarum MBI600 (NRRL B-50595, deposited at USDA) (e. g.

Integral®, Subtilex® NG from BASF Corp., USA), B. cereus CNCM 1-1562 (US 6,406,690), B. firmus CNCM 1-1582 (WO 2009/126473, WO 2009/124707, US 6,406,690; Votivo® from Bayer Crop Science LP, USA),

[00075] B. pumilus GB34 (ATCC 700814; e. g. in YieldShield® from Gustafson LLC, TX, USA),

[00076] Bacillus pumilus KFP9F (NRRL B-50754) (e. g. in BAC-UP or FUSION-P from BASF Agricultural Specialities (Pty) Ltd., South Africa), B. pumilus QST 2808 (NRRL B 30087) (e. g. Sonata® and Ballad® Plus from AgraQuest Inc., USA),

[00077] B. subtilis CX-9060 (Federeal Register 77(7), 1633-1637; Certis U.S.A., L.L.C.), B. subtilis GB03 (e. g. Kodiak® or BioYield® from Gustafson, Inc., USA; or Companion® from Growth Products, Ltd., White Plains, NY 10603, USA), B. subtilis GB07 (Epic® from Gustafson, Inc., USA), B. subtilis QST-713 (NRRL B 21661 in Rhapsody®, Serenade® MAX and

Serenade® ASO from AgraQuest Inc., USA), B. subtilis var. amyloliquefaciens FZB24 (e. g. Taegro® from Novozyme Biologicals, Inc., USA), B. subtilis var. amyloliquefaciens D747 (FERM BP-8234; KR 100903253; e. g. Double Nickel™ 55 WDG or Double Nickel™ LC from Certis LLC, USA),

[00078] B. thuringiensis ssp. aizawai ABTS-1857 (e. g. in XenTari® from BioFa AG,

Munsingen, Germany), B. t. ssp. aizawai SAN 401 I, ABG-6305 and ABG-6346, Bacillus t. ssp. israelensis AM65-52 (e. g. in VectoBac® from Valent Biosciences, IL, USA), Bacillus

thuringiensis ssp. kurstaki SB4 (NRRL B-50753; e. g. Beta Pro® from BASF Agricultural Specialities (Pty) Ltd., South Africa), B. t. ssp. kurstaki ABTS-351 identical to HD-1 (ATCC SD- 1275; e. g. in Dipel® DF from Valent Biosciences, IL, USA), B. t. ssp. kurstaki EG 2348 (e. g. in Lepinox® or Rapax® from CBC (Europe) S.r.l., Italy), B. t. ssp. tenebrionis DSM 2803 (EP 0 585 215 B1 ; identical to NRRL B-15939; Mycogen Corp.), B. t. ssp. tenebrionis NB-125 (DSM 5526; EP 0 585 215 B1 ; also referred to as SAN 418 I or ABG-6479; former production strain of Novo-Nordisk), B. t. ssp. tenebrionis NB-176 (or NB-176-1 ; a gamma-irridated, induced high- yielding mutant of strain NB-125; DSM 5480; EP 585 215 B1 ; Novodor® from Valent

Biosciences, Switzerland), Beauveria bassiana ATCC 74040 (e. g. in Naturalis® from CBC (Europe) S.r.l., Italy), B. bassiana DSM 12256 (US 200020031495; e. g. BioExpert® SC from Live Sytems Technology S.A., Colombia), B. bassiana GHA (BotaniGard® 22WGP from

Laverlam Int. Corp., USA), B. bassiana PPRI 5339 (ARSEF number 5339 in the USDA ARS collection of entomopathogenic fungal cultures; NRRL 50757) (e. g. BroadBand® from BASF Agricultural Specialities (Pty) Ltd., South Africa), B. brongniartii (e. g. in Melocont® from

Agrifutur, Agrianello, Italy, for control of cockchafer; J. Appl. Microbiol. 100(5), 1063-72, 2006), [00079] Bradyrhizobium sp. (e. g. Vault® from BASF Corp., USA), B. japonicum (e. g.

VAULT® from BASF Corp., USA), [00080] Burkholderia sp. A396 (NRRL B-50319; WO 2013/032693; Marrone Bio Innovations, Inc., USA), Candida oleophila 1-182 (NRRL Y-18846; e. g. Aspire® from Ecogen Inc., USA, [00081 ] Phytoparasitica 23(3), 231 -234, 1995), C. oleophila strain O (NRRL Y-2317;

Biological Control 51 , 403-408, 2009), Candida saitoana (e. g. Biocure® (in mixture with lysozyme) and BioCoat® from Micro Flo Company, USA (BASF SE) and Arysta), chitosan (e. g. Armour-Zen® from BotriZen Ltd., NZ), Clonostachys rosea f. catenulata, also named

Gliocladium catenulatum (e. g. isolate J 1446: Prestop® from Verdera Oy, Finland),

Chromobacterium subtsugae PRAA4-1 isolated from soil under an eastern hemlock (Tsuga canadensis) in the Catoctin Mountain region of central Maryland (e. g. in GRANDEVO from Marrone Bio Innovations, USA),

[00082] Coniothyrium minitans CON/M/91 -08 (DSM 9660; e. g. Contans® WG, Intercept® WG from Prophyta Biologischer Pflanzenschutz GmbH, Germany; WO 1996/021358),

[00083] Cryphonectria parasitica (e. g. product Endothia parasitica from CNICM, France), Cryptococcus albidus (e. g. YIELD PLUS® from Anchor Bio-Technologies, South Africa), Cryptophlebia leucotreta granulovirus (CrleGV) (e. g. in CRYPTEX from Adermatt Biocontrol, Switzerland), Cydia pomonella granulovirus (CpGV) V03 (DSM GV-0006; e. g. in MADEX Max from Andermatt Biocontrol, Switzerland), CpGV V22 (DSM GV-0014; e. g. in MADEX Twin from Adermatt Biocontrol, Switzerland), Delftia acidovorans RAY209 (ATCC PTA-4249; WO

2003/57861 ; e. g. in BIOBOOST from Brett Young, Winnipeg, Canada), Dilophosphora alopecuri (Twist Fungus from BASF Agricultural Specialties Pty Ltd, Australia), Ecklonia maxima (kelp) extract (e. g. KELPAK SL from Kelp Products Ltd, South Africa), Flavobacterium sp. H492 (ATCC B-505584, WO 2013/138398), formononetin (e. g. in MYCONATE from Plant Health Care pic, U.K.), Fusarium oxysporum (e. g. BIOFOX® from S.I.A.P.A., Italy, FUSACLEAN® from Natural Plant Protection, France), Glomus intraradices (e. g. MYC 4000 from ITHEC, France), Glomus intraradices RTI-801 (e. g. MYKOS from Xtreme Gardening, USA or RTI Reforestation Technologies International; USA), grapefruit seeds and pulp extract (e. g. BC- 1000 from Chemie S.A., Chile), harpin (alpha-beta) protein (e. g. MESSENGER or HARP-N Tek from Plant Health Care pic, U.K.; Science 257, 1-132, 1992), Helicoverpa armigera

nucleopolyhedrovirus (HearNPV) (e.g. in HELICOVEX from Adermatt Biocontrol, Switzerland), Heterorhabditis bacteriophaga (e. g. Nemasys® G from BASF Agricultural Specialities Limited, UK), Isaria fumosorosea Apopka-97 (ATCC 20874) (PFR-97™ from Certis LLC, USA), cis- jasmone (US 8,221 ,736), laminarin (e. g. in VACCI PLANT from Laboratoires Goemar, St. Malo, France or Stahler SA, Switzerland), Lecanicillium longisporum KV42 and KV71 (e. g.

VERTALEC® from Koppert BV, Netherlands), L. muscarium KV01 (formerly Verticillium lecanii) (e. g. MYCOTAL from Koppert BV, Netherlands), Lysobacter antibioticus 13-1 (Biological

Control 45, 288-296, 2008), L. antibioticus HS124 (Curr. Microbiol. 59(6), 608-615, 2009), L. enzymogenes 3.1 T8 (Microbiol. Res. 158, 107-1 15; Biological Control 31 (2), 145-154, 2004), Metarhizium anisopliae var. acridum IMI 330189 (isolated from Ornithacris cavroisi in Niger; NRRL 50758) (e. g. GREEN MUSCLE® from BASF Agricultural Specialities (Pty) Ltd., South Africa), M. a. var. acridum FI-985 (e. g. GREEN GUARD® SC from BASF Agricultural

Specialties Pty Ltd, Australia), M. anisopliae FI-1045 (e. g. BIOCANE® from BASF Agricultural Specialties Pty Ltd, Australia), M. anisopliae F52 (DSM 3884, ATCC 90448; e. g. MET52® Novozymes Biologicals BioAg Group, Canada), M. anisopliae ICIPE 69 (e. g. METATHRIPOL from ICIPE, Nairobe, Kenya), Metschnikowia fructicola (NRRL Y-30752; e. g. SHEMER® from Agrogreen, Israel, now distributed by Bayer CropSciences, Germany; US 6,994,849),

Microdochium dimerum (e. g. ANTIBOT® from Agrauxine, France), Microsphaeropsis ochracea P130A (ATCC 74412 isolated from apple leaves from an abandoned orchard, St-Joseph-du- Lac, Quebec, Canada in 1993; Mycologia 94(2), 297-301 , 2002), Muscodor albus QST 20799 originally isolated from the bark of a cinnamon tree in Honduras (e. g. in development products Muscudor™ or QRD300 from AgraQuest, USA), Neem oil (e.g. TRILOGY®, TRIACT® 70 EC from Certis LLC, USA), Nomuraea rileyi strains SA86101 , GU87401 , SR86151 , CG128 and VA9101 ,

[00084] Paecilomyces fumosoroseus FE 9901 (e. g. NO FLY™ from Natural Industries, Inc., USA), P. lilacinus 251 (e. g. in BioAct®/MeloCon® from Prophyta, Germany; Crop Protection 27, 352-361 , 2008; originally isolated from infected nematode eggs in the Philippines), P.

lilacinus DSM 15169 (e. g. NEMATA® SC from Live Systems Technology S.A., Colombia), P. lilacinus BCP2 (NRRL 50756; e. g. PL GOLD from BASF Agricultural Specialities (Pty) Ltd., South Africa),

[00085] mixture of Paenibacillus alvei NAS6G6 (NRRL B-50755) and Bacillus pumilus (e.g. BAC-UP from BASF Agricultural Specialities (Pty) Ltd., South Africa),

[00086] Pantoea vagans (formerly agglomerans) C9-1 (originally isolated in 1994 from apple stem tissue; BlightBan C9-1® from NuFrams America Inc., USA, for control of fire blight in apple; J. Bacteriol. 192(24) 6486-6487, 2010),

[00087] Pasteuria sp. ATCC PTA-9643 (WO 2010/085795), P. nishizawae Pn1 (e.g.

CLARIVA PN from Syngenta Crop Protection, LLC, Greenborom ;C, USA), Pasteuria sp. ATCC SD-5832 (WO 2012/064527), P. nishizawae (WO 2010/80169), P. penetrans (US 5,248,500), P. ramose (WO 2010/80619), P. thornea (WO 2010/80169), P. usgae (WO 2010/80169),

[00088] Penicillium bilaiae (e. g. Jump Start® from Novozymes Biologicals BioAg Group, Canada, originally isolated from soil in southern Alberta; Fertilizer Res. 39, 97-103, 1994),

[00089] Phlebiopsis gigantea (e. g. RotStop® from Verdera Oy, Finland), Pichia anomala WRL-076 (NRRL Y-30842; US 8,206,972), potassium bicarbonate (e. g. Amicarb® from Stahler SA, Switzerland), potassium silicate (e. g. Sil-MATRIX™ from Certis LLC, USA), Pseudozyma flocculosa PF-A22 UL (e. g. Sporodex® from Plant Products Co. Ltd., Canada),

[00090] Pseudomonas sp. DSM 13134 (WO 2001/40441 , e. g. in PRO RAD IX from Sourcon Padena GmbH & Co. KG, Hechinger Str. 262, 72072 Tubingen, Germany), P. chloraphis MA 342 (e. g. in CERALL or CEDEMON from BioAgri AB, Uppsala, Sweden), P. fluorescens CL 145A (e. g. in ZEQUANOX from Marrone Biolnnovations, Davis, CA, USA; J. Invertebr. Pathol. 1 13(1 ):104-14, 2013),

[00091 ] Pythium oligandrum DV 74 (ATCC 38472; e. g. POLYVERSUM® from Remeslo SSRO, Biopreparaty, Czech Rep. and GOWAN, USA; US 2013/0035230), Reynoutria sachlinensis extract (e. g. REGALIA® SC from Marrone Biolnnovations, Davis, CA, USA),

[00092] Rhizobium leguminosarum bv. phaseoli (e. g. RHIZO-STICK from BASF Corp., USA), R. I. bv. trifolii RP1 13-7 (e. g. DORMAL from BASF Corp., USA; Appl. Environ. Microbiol. 44(5), 1096-1 101 ), R. I. bv. viciae P1 NP3Cst (also referred to as 1435; New Phytol. 179(1 ), 224- 235, 2008; e. g. in NODULATOR PL Peat Granule from BASF Corp., USA; or in NODULATOR XL PL from BASF Agricultural Specialties Ltd., Canada), R. I. bv. viciae SU303 (e. g.

NODULAID Group E from BASF Agricultural Specialties Pty Ltd, Australia), R. I. bv. viciae WSM1455 (e. g. NODULAID Group F from BASF Agricultural Specialties Pty Ltd, Australia), R. tropici SEMIA 4080 (identical to PRF 81 ; Soil Biology & Biochemistry 39, 867-876, 2007),

[00093] Sinorhizobium meliloti MSDJ0848 (INRA, France) also referred to as strain 201 1 or RCR201 1 (Mol. Gen. Genomics 272, 1-17, 2004; e. g. DORMAL ALFALFA from BASF Corp., USA; NITRAGIN® Gold from Novozymes Biologicals BioAg Group, Canada),

[00094] Sphaerodes mycoparasitica IDAC 301008-01 (WO 201 1/022809), Spodoptera littoralis nucleopolyhedrovirus (SpliNPV) (e.g. in LITTOVIR from Adermatt Biocontrol,

Switzerland), Steinernema carpocapsae (e. g. MILLENIUM® from BASF Agricultural

Specialities Limited, UK), S. feltiae (NEMASHIELD® from BioWorks, Inc., USA; NEMASYS® from BASF Agricultural Specialities Limited, UK), S. kraussei L137 (NEMASYS® L from BASF Agricultural Specialities Limited, UK), Streptomyces griseoviridis K61 (e. g. MYCOSTOP® from Verdera Oy, Espoo, Finland; Crop Protection 25, 468-475, 2006), S. lydicus WYEC 108 (e. g. Actinovate® from Natural Industries, Inc., USA, US 5,403,584), S. violaceusniger YCED-9 (e. g. DT-9® from Natural Industries, Inc., USA, US 5,968,503), Talaromyces flavus V1 17b (e. g. PROTUS® from Prophyta, Germany),

[00095] Trichoderma asperellum SKT-1 (e. g. ECO-HOPE® from Kumiai Chemical Industry Co., Ltd., Japan), T. asperellum ICC 012 (e. g. in TENET WP, REMDIER WP, BIOTEN WP from Isagro NC, USA, BIO-TAM from AgraQuest, USA), T. atroviride LC52 (e. g. SENTINEL® from Agrimm Technologies Ltd, NZ), T. atroviride CNCM 1-1237 (e. g. in Esquive WG from Agrauxine S.A., France, e. g. against pruning wound diseases on vine and plant root pathogens), T. fertile JM41 R (NRRL 50759; e. g. TRICHOPLUS™ from BASF Agricultural Specialities (Pty) Ltd., South Africa), T. gamsii ICC 080 (e. g. in TENET WP, REMDIER WP, BIOTEN WP from Isagro NC, USA, BIO-TAM from AgraQuest, USA), T. harzianum T-22 (also called KRL-AG2; ATCC 20847; e. g. PLANTSHIELD® from BioWorks Inc., USA or SabrEx™ from Advanced Biological Marketing Inc., Van Wert, OH, USA; BioControl 57, 687-696, 2012), T. harzianum TH 35 (e. g. ROOT PRO® from Mycontrol Ltd., Israel), T. harzianum T-39 (e. g. TRICHODEX® and

TRICHODERMA 2000® from Mycontrol Ltd., Israel and Makhteshim Ltd., Israel), mixture of T. harzianum and T. viride (e. g. TRICHOPEL from Agrimm Technologies Ltd, NZ), T. harzianum ICC012 and T. viride ICC080 (e. g. REMEDIER® WP from Isagro Ricerca, Italy), T. polysporum and T. harzianum (e. g. BINAB® from BINAB Bio-Innovation AB, Sweden), T. stromaticum (e. g. TRICOVAB® from C.E.P.L.A.C., Brazil), T. virens G1 -3 (also called GI-3; ATCC 58678; e.g. QuickRoots™ from TJ Technologies, Watertown, SD, USA; CA 2471555 A1 ), T. virens GL-21 (also called G1 -21 ; US 7429477 B2; e. g. SOILGARD® 12G from Certis LLC, USA, EPA Registration Number: 70051 -3 and EPA Establishment Number: 067250-IL-001 ), T. virens G-41 (also called 041 , #41X or ABM 127; isolated from soil samples taken from Aphanomyces- suppressive bean fields in Livingston County, New York; US 4,996,157; e. g. ROOTSHIELD® PLUS from BioWorks, Inc., USA), T. viride (e. g. TRIECO® from Ecosense Labs. (India) Pvt. Ltd., Indien, BIO-CURE® F from T. Stanes & Co. Ltd., Indien), T. viride TV1 (e. g. T. viride TV1 from Agribiotec srl, Italy) and

[00096] Ulocladium oudemansii HRU3 (e. g. in BOTRY-ZEN® from Botry-Zen Ltd, NZ).

[00097] Even more preferred biologicals to be used in the process according to the present invention include the following substances and mixtures thereof:

[00098] Azospirillum amazonense BR 1 1 140 (SpY2T) (Proc. 9th Int. and 1 st Latin American PGPR meeting, Quimara, Medellin, Colombia 2012, p. 60, ISBN 978-958-46-0908-3), A. brasilense AZ39 (Eur. J. Soil Biol 45(1 ), 28-35, 2009), A. brasilense XOH (e. g. AZOS from Xtreme Gardening, USA or RTI Reforestation Technologies International; USA), A. brasilense BR 1 1002 (Proc. 9th Int. and 1 st Latin American PGPR meeting, Quimara, Medellin, Colombia 2012, p. 60, ISBN 978-958-46-0908-3), A. brasilense BR 1 1005 (SP245; e. g. in GELFIX Gramineas from BASF Agricultural Specialties Ltd., Brazil), A. brasilense strains Ab-V5 and Ab- V6 (e. g. in AzoMax from Novozymes BioAg Produtos papra Agricultura Ltda., Quattro Barras, Brazil or SimbioseMaiz® from Simbiose-Agro, Cruz Alta, RS, Brazil; Plant Soil 331 , 413-425, 2010), A. lipoferum BR 1 1646 (Sp31 ) (Proc. 9th Int. and 1 st Latin American PGPR meeting, Quimara, Medellin, Colombia 2012, p. 60),

[00099] Bacillus amyloliquefaciens FZB42 (e. g. in RhizoVital® 42 from AbiTEP GmbH,

Berlin, Germany), B. amyloliquefaciens IN937a (J. Microbiol. Biotechnol. 17(2), 280-286, 2007; e. g. in BioYield® from Gustafson LLC, TX, USA), B. amyloliquefaciens IT-45 (CNCM I 3800) (e. g. Rhizocell C from ITHEC, France), B. amyloliquefaciens TJ1000 (also called 1 BE; ATCC BAA- 390; e.g. QuickRoots™ from TJ Technologies, Watertown, SD, USA; CA 2471555 A1 ), B.

amyloliquefaciens ssp. plantarum MBI600 (NRRL B-50595, deposited at USDA) (e. g. Integral®, Subtilex® NG from BASF Corp., USA), B. cereus CNCM 1-1562 (US 6,406,690), B. firmus CNCM 1-1582 (WO 2009/126473, WO 2009/124707, US 6,406,690; Votivo® from Bayer Crop Science LP, USA),

[000100] B. pumilus GB34 (ATCC 700814; e. g. in YieldShield® from Gustafson LLC, TX, USA),

[000101 ] Bacillus pumilus KFP9F (NRRL B-50754) (e. g. in BAC-UP or FUSION-P from BASF Agricultural Specialities (Pty) Ltd., South Africa), B. pumilus QST 2808 (NRRL B 30087) (e. g. Sonata® and Ballad® Plus from AgraQuest Inc., USA),

[000102] B. subtilis CX-9060 (Federeal Register 77(7), 1633-1637; Certis U.S.A., L.L.C.), B. subtilis GB03 (e. g. Kodiak® or BioYield® from Gustafson, Inc., USA; or Companion® from

Growth Products, Ltd., White Plains, NY 10603, USA), B. subtilis GB07 (Epic® from Gustafson, Inc., USA), B. subtilis QST-713 (NRRL B 21661 in Rhapsody®, Serenade® MAX and

Serenade® ASO from AgraQuest Inc., USA), B. subtilis var. amyloliquefaciens FZB24 (e. g. Taegro® from Novozyme Biologicals, Inc., USA), B. subtilis var. amyloliquefaciens D747 (FERM BP-8234; KR 100903253; e. g. Double Nickel™ 55 WDG or Double Nickel™ LC from Certis LLC, USA),

[000103] Bradyrhizobium sp. (e. g. Vault® from BASF Corp., USA), B. japonicum (e. g.

VAULT® from BASF Corp., USA),

[000104] Burkholderia sp. A396 (NRRL B-50319; WO 2013/032693; Marrone Bio Innovations, Inc., USA), Candida oleophila 1-182 (NRRL Y-18846; e. g. Aspire® from Ecogen Inc., USA, [000105] Coniothyrium minitans CON/M/91 -08 (DSM 9660; e. g. Contans® WG, Intercept® WG from Prophyta Biologischer Pflanzenschutz GmbH, Germany; WO 1996/021358),

[000106] Paecilomyces fumosoroseus FE 9901 (e. g. NO FLY™ from Natural Industries, Inc., USA), P. lilacinus 251 (e. g. in BioAct®/MeloCon® from Prophyta, Germany; Crop Protection 27, 352-361 , 2008; originally isolated from infected nematode eggs in the Philippines), P.

lilacinus DSM 15169 (e. g. NEMATA® SC from Live Systems Technology S.A., Colombia), P. lilacinus BCP2 (NRRL 50756; e. g. PL GOLD from BASF Agricultural Specialities (Pty) Ltd., South Africa), [000107] mixture of Paenibacillus alvei NAS6G6 (NRRL B-50755) and Bacillus pumilus (e.g. BAC-UP from BASF Agricultural Specialities (Pty) Ltd., South Africa),

[000108] Pasteuria sp. ATCC PTA-9643 (WO 2010/085795), P. nishizawae Pn1 (e.g.

CLARIVA PN from Syngenta Crop Protection, LLC, Greenborom ;C, USA), Pasteuria sp. ATCC SD-5832 (WO 2012/064527), P. nishizawae (WO 2010/80169), P. penetrans (US 5,248,500), P. ramose (WO 2010/80619), P. thornea (WO 2010/80169), P. usgae (WO 2010/80169),

[000109] Penicillium bilaiae (e. g. Jump Start® from Novozymes Biologicals BioAg Group, Canada, originally isolated from soil in southern Alberta; Fertilizer Res. 39, 97-103, 1994),

[0001 10] Pseudomonas sp. DSM 13134 (WO 2001/40441 , e. g. in PRO RAD IX from Sourcon Padena GmbH & Co. KG, Hechinger Str. 262, 72072 Tubingen, Germany), P. chloraphis MA 342 (e. g. in CERALL or CEDEMON from BioAgri AB, Uppsala, Sweden), P. fluorescens CL 145A (e. g. in ZEQUANOX from Marrone Biolnnovations, Davis, CA, USA; J. Invertebr. Pathol. 1 13(1 ):104-14, 2013),

[0001 1 1 ] Rhizobium leguminosarum bv. phaseoli (e. g. RHIZO-STICK from BASF Corp., USA), R. I. bv. trifolii RP1 13-7 (e. g. DORMAL from BASF Corp., USA; Appl. Environ. Microbiol. 44(5), 1096-1 101 ), R. I. bv. viciae P1 NP3Cst (also referred to as 1435; New Phytol. 179(1 ), 224- 235, 2008; e. g. in NODULATOR PL Peat Granule from BASF Corp., USA; or in NODULATOR XL PL from BASF Agricultural Specialties Ltd., Canada), R. I. bv. viciae SU303 (e. g.

NODULAID Group E from BASF Agricultural Specialties Pty Ltd, Australia), R. I. bv. viciae WSM1455 (e. g. NODULAID Group F from BASF Agricultural Specialties Pty Ltd, Australia), R. tropici SEMIA 4080 (identical to PRF 81 ; Soil Biology & Biochemistry 39, 867-876, 2007),

[0001 12] Sinorhizobium meliloti MSDJ0848 (INRA, France) also referred to as strain 201 1 or RCR201 1 (Mol. Gen. Genomics 272, 1-17, 2004; e. g. DORMAL ALFALFA from BASF Corp., USA; NITRAGIN® Gold from Novozymes Biologicals BioAg Group, Canada),

[0001 13] Trichoderma asperellum SKT-1 (e. g. ECO-HOPE® from Kumiai Chemical Industry Co., Ltd., Japan), T. asperellum ICC 012 (e. g. in TENET WP, REMDIER WP, BIOTEN WP from Isagro NC, USA, BIO-TAM from AgraQuest, USA), T. atroviride LC52 (e. g. SENTINEL® from Agrimm Technologies Ltd, NZ), T. atroviride CNCM 1-1237 (e. g. in Esquive WG from Agrauxine S.A., France, e. g. against pruning wound diseases on vine and plant root pathogens), T. fertile JM41 R (NRRL 50759; e. g. TRICHOPLUS™ from BASF Agricultural Specialities (Pty) Ltd.,

South Africa), T. gamsii ICC 080 (e. g. in TENET WP, REMDIER WP, BIOTEN WP from Isagro NC, USA, BIO-TAM from AgraQuest, USA), T. harzianum T-22 (also called KRL-AG2; ATCC 20847; e. g. PLANTSHIELD® from BioWorks Inc., USA or SabrEx™ from Advanced Biological Marketing Inc., Van Wert, OH, USA; BioControl 57, 687-696, 2012), T. harzianum TH 35 (e. g. ROOT PRO® from Mycontrol Ltd., Israel), T. harzianum T-39 (e. g. TRICHODEX® and

TRICHODERMA 2000® from Mycontrol Ltd., Israel and Makhteshim Ltd., Israel), mixture of T. harzianum and T. viride (e. g. TRICHOPEL from Agrimm Technologies Ltd, NZ), T. harzianum ICC012 and T. viride ICC080 (e. g. REMEDIER® WP from Isagro Ricerca, Italy), T. polysporum and T. harzianum (e. g. BINAB® from BINAB Bio-Innovation AB, Sweden), T. stromaticum (e. g. TRICOVAB® from C.E.P.L.A.C., Brazil), T. virens G1 -3 (also called GI-3; ATCC 58678; e.g. QuickRoots™ from TJ Technologies, Watertown, SD, USA; CA 2471555 A1 ), T. virens GL-21 (also called G1 -21 ; US 7429477 B2; e. g. SOILGARD® 12G from Certis LLC, USA, EPA

Registration Number: 70051 -3 and EPA Establishment Number: 067250-IL-001 ), T. virens G-41 (also called 041 , #41 X or ABM 127; isolated from soil samples taken from Aphanomyces- suppressive bean fields in Livingston County, New York; US 4,996,157; e. g. ROOTSHIELD® PLUS from BioWorks, Inc., USA), T. viride (e. g. TRIECO® from Ecosense Labs. (India) Pvt. Ltd., Indien, BIO-CURE® F from T. Stanes & Co. Ltd., Indien), T. viride TV1 (e. g. T. viride TV1 from Agribiotec srl, Italy).

[0001 14] The most preferred biologicals to be used in the process according to the present invention include the following substances and mixtures thereof:

[0001 15] A. brasilense XOH (e. g. AZOS from Xtreme Gardening, USA or RTI Reforestation Technologies International; USA), A. brasilense BR 1 1002 (Proc. 9th Int. and 1 st Latin

American PGPR meeting, Quimara, Medellin, Colombia 2012, p. 60, ISBN 978-958-46-0908-3), A. brasilense BR 1 1005 (SP245; e. g. in GELFIX Gramineas from BASF Agricultural Specialties Ltd., Brazil), A. brasilense strains Ab-V5 and Ab-V6 (e. g. in AzoMax from Novozymes BioAg Produtos papra Agricultura Ltda., Quattro Barras, Brazil or SimbioseMaiz® from Simbiose-Agro, Cruz Alta, RS, Brazil; Plant Soil 331 , 413-425, 2010),

[0001 16] Bacillus amyloliquefaciens FZB42 (e. g. in RhizoVital® 42 from AbiTEP GmbH, Berlin, Germany), B. amyloliquefaciens IN937a (J. Microbiol. Biotechnol. 17(2), 280-286, 2007; e. g. in BioYield® from Gustafson LLC, TX, USA), B. amyloliquefaciens IT-45 (CNCM I 3800) (e. g. Rhizocell C from ITHEC, France), B. amyloliquefaciens TJ1000 (also called 1 BE; ATCC BAA-

390; e.g. QuickRoots™ from TJ Technologies, Watertown, SD, USA; CA 2471555 A1 ), B.

amylolique-"faciens ssp. plantarum MBI600 (NRRL B-50595, deposited at USDA) (e. g.

Integral®, Subtilex® NG from BASF Corp., USA), B. cereus CNCM 1-1562 (US 6,406,690), B. firmus CNCM 1-1582 (WO 2009/126473, WO 2009/124707, US 6,406,690; Votivo® from Bayer

Crop Science LP, USA),

[0001 17] Bacillus pumilus KFP9F (NRRL B-50754) (e. g. in BAC-UP or FUSION-P from BASF Agricultural Specialities (Pty) Ltd., South Africa), B. pumilus QST 2808 (NRRL B 30087) (e. g. Sonata® and Ballad® Plus from AgraQuest Inc., USA),

[0001 18] B. japonicum (e. g. VAULT® from BASF Corp., USA),

[0001 19] Coniothyrium minitans CON/M/91 -08 (DSM 9660; e. g. Contans® WG, Intercept® WG from Prophyta Biologischer Pflanzenschutz GmbH, Germany; WO 1996/021358),

[000120] P. nishizawae Pn1 (e.g. CLARIVA PN from Syngenta Crop Protection, LLC, Greenborom ;C, USA),

[000121 ] Penicillium bilaiae (e. g. Jump Start® from Novozymes Biologicals BioAg Group, Canada, originally isolated from soil in southern Alberta; Fertilizer Res. 39, 97-103, 1994),

[000122] P. fluorescens CL 145A (e. g. in ZEQUANOX from Marrone Biolnnovations, Davis, CA, USA; J. Invertebr. Pathol. 1 13(1 ):104-14, 2013),

[000123] Rhizobium leguminosarum bv. phaseoli (e. g. RHIZO-STICK from BASF Corp.,

USA), R. I. bv. trifolii RP1 13-7 (e. g. DORMAL from BASF Corp., USA; Appl. Environ. Microbiol. 44(5), 1096-1 101 ), R. I. bv. viciae P1 NP3Cst (also referred to as 1435; New Phytol. 179(1 ), 224- 235, 2008; e. g. in NODULATOR PL Peat Granule from BASF Corp., USA; or in NODULATOR XL PL from BASF Agricultural Specialties Ltd., Canada), R. I. bv. viciae SU303 (e. g.

NODULAID Group E from BASF Agricultural Specialties Pty Ltd, Australia), R. I. bv. viciae

WSM1455 (e. g. NODULAID Group F from BASF Agricultural Specialties Pty Ltd, Australia), R. tropici SEMIA 4080 (identical to PRF 81 ; Soil Biology & Biochemistry 39, 867-876, 2007), [000124] Sinorhizobium meliloti MSDJ0848 (INRA, France) also referred to as strain 201 1 or RCR201 1 (Mol. Gen. Genomics 272, 1-17, 2004; e. g. DORMAL ALFALFA from BASF Corp., USA; NITRAGIN® Gold from Novozymes Biologicals BioAg Group, Canada),

[000125] T. fertile JM41 R (NRRL 50759; e. g. TRICHOPLUS™ from BASF Agricultural Specialities (Pty) Ltd., South Africa).

[000126] The biological is present in the formulations for agricultural end use in an amount of 1 X10 2 to 1X10 8 CFU/gram, preferably1X10 3 to 1X10 7 CFU/gram, and even more preferably 5X10 3 to 5X10 5 CFU/gram based on the total composition.

[000127] Preferred nutrients to be used in the compositions according to the present invention include the following substances and mixtures thereof:

[000128] Alpha-tocopherol, trehalose, glutamate, potassium sorbate, various sugars like glucose, sucrose, lactose and maltodextrine (see H.D. Burges: Formulation of Micobial

Biopestcides, Springer, 1998).

[000129] The nutrients are present in the formulations for agricultural end use in an amount of 0.001 to1 .0 % by weight, preferably 0.005 to 0.5 % by weight, and even more preferably 0.01 to 0.1 % by weight based on the total composition.

[000130] The compositions according to the present invention can be converted into those customary types of herbicidal formulations comprising clomazone which are common in the agricultural industry including solutions, emulsions, suspensions, dusts, powders, pastes and granules.

[000131 ] The composition type depends on the particular intended purpose; in each case, it should ensure a fine and uniform distribution of the compounds according to the invention.

[000132] The present invention refers to two basic types of formulation: In the first type of formulations, stock formulations or formulation concentrates of the respective active

compounds, e.g. for storage before use, are meant. The various active ingredients can be kept in separate formulations before use and the actual application formulation for agricultural end use (which is the second type of formulation, e.g. a tank mix or spray solution), can be prepared from the first type of formulation right before the agricultural application. Such concentration may require further dilution upon application on the agricultural field.

[000133] In the second type of formulation, the formulation for agricultural end use, typical tank mixes, spray solutions, application fluids or the like are meant. The latter second type of formulations is ready to use, i.e. ready to be applied, on the corresponding agricultural area without further dilution or modification. That is, the second type of tank mix compositions already contains the corresponding mixture of active compounds (A) and (B) in the required

concentration and required relative amount to be directly applied during the agricultural end use on the agricultural field. The concentrations of the active compounds according to the present invention therefore refer to the effective concentrations required for agricultural end use, e.g. as so-called tank-mix or spray solution concentrations.

[000134] Preferred examples of the first type of formulation are composition types like suspensions (SC, OD, FS), emulsifiable concentrates (EC), emulsions (EW - water emulsion -, EO, ES), pastes, pastilles, while wettable powders or dusts (WP, SP, SS, WS, DP, DS) or granules (GR, FG, GG, MG), which can be water-soluble or wettable, as well as gel

formulations for the treatment of plant propagation materials such as seeds (GF) are less preferred. Suspensions, emulsifiable concentrates, and emulsions are especially preferred formulations for the compositions according to the present invention. Usually the composition types (e. g. SC, OD, FS, EC, WG, SG, WP, SP, SS, WS, GF) are employed diluted.

Composition types such as DP, DS, GR, FG, GG and MG are usually used undiluted.

[000135] The compositions are prepared in a known manner. When the herbicidal

composition according to the present invention is an aqueous formulation, the salt according to the present invention may dissociate into anions and cations. The compositions may also comprise auxiliaries which are customary in agrochemical formulations. The auxiliaries used depend on the particular application form and active substance, respectively.

[000136] Examples for suitable auxiliaries are solvents, solid carriers, dispersants or emulsifiers (such as further solubilizers, protective colloids, surfactants and adhesion agents), organic and anorganic thickeners, bactericides, anti-freezing agents, anti-foaming agents, if appropriate colorants and tackifiers or binders (e. g. for seed treatment formulations). Suitable solvents are water, organic solvents such as mineral oil fractions of medium to high boiling point, such as kerosene or diesel oil, furthermore coal tar oils and oils of vegetable or animal origin, aliphatic, cyclic and aromatic hydrocarbons, e. g. toluene, xylene, paraffin,

tetrahydronaphthalene, alkylated naphthalenes or their derivatives, alcohols such as methanol, ethanol, propanol, butanol and cyclohexanol, glycols (such as ethylene glycol or 1 ,2-propylene glycol), ketones such as cyclohexanone and gamma-butyrolactone, fatty acid dimethylamides, fatty acids and fatty acid esters and strongly polar solvents, e. g. amines such as N- methylpyrrolidone. Preferred solvent is water.

[000137] Solid carriers are mineral earths such as silicates, silica gels, talc, kaolins, limestone, lime, chalk, bole, loess, clays, dolomite, diatomaceous earth, calcium sulfate, magnesium sulfate, iron sulfate, magnesium oxide, ground synthetic materials, fertilizers, such as, e. g., ammonium sulfate, ammonium phosphate, ammonium nitrate, ureas, and products of vegetable origin, such as cereal meal, tree bark meal, wood meal and nutshell meal, cellulose powders and other solid carriers.

[000138] Suitable surfactants (adjuvants, wetters, tackifiers, dispersants or emulsifiers) are alkali metal, alkaline earth metal and ammonium salts of aromatic sulfonic acids, such as ligninsoulfonic acid (Borresperse<(R)> types, Borregard, Norway) phenolsulfonic acid, naphthalenesulfonic acid (Morwet<(R)> types, Akzo Nobel, U.S.A.), dibutylnaphthalene- sulfonic acid (Nekal<(R)> types, BASF, Germany), and fatty acids, alkylsulfonates, alkyl- arylsulfonates, alkyl sulfates, laurylether sulfates, fatty alcohol sulfates, and sulfated hexa-, hepta- and octadecanolates, sulfated fatty alcohol glycol ethers, furthermore condensates of naphthalene or of naphthalenesulfonic acid with phenol and formaldehyde, polyoxy-ethylene octylphenyl ether, ethoxylated isooctylphenol, octylphenol, nonylphenol, alkylphenyl polyglycol ethers, tributylphenyl polyglycol ether, tristearyl- phenyl polyglycol ether, alkylaryl polyether alcohols, alcohol and fatty alcohol/ethylene oxide condensates, ethoxylated castor oil, polyoxyethylene alkyl ethers, ethoxylated polyoxypropylene, lauryl alcohol polyglycol ether acetal, sorbitol esters, lignin-sulfite waste liquors and proteins, denatured proteins, polysaccharides (e. g.

methylcellulose), hydrophobically modified starches, polyvinyl alcohols (Mowiol<(R)> types, Clariant, Switzerland), polycarboxylates (Sokolan<(R)> types, BASF, Germany),

polyalkoxylates, polyvinyl- amines (Lupasol<(R)> types, BASF, Germany), polyvinylpyrrolidone and the copolymers thereof. Further suitable surfactants (especially for agrochemical compositions comprising glyphosate) are alkoxylated C4-22-alkylamines, such as ethoxylated tallow amine (POEA) and the surfactants disclosed in EP1389040 (e.g. those in Examples 1 to 14).

[000139] Examples for thickeners (i. e. compounds that impart a modified flowability to the compositions, i.e. high viscosity under static conditions and low viscosity during agitation) are polysaccharides and organic and anorganic clays such as Xanthan gum (Kelzan<(R)>, CP

Kelco, U.S.A.), Rhodopol<(R)> 23 (Rhodia, France), Veegum<(R)> (R.T. Vanderbilt, U.S.A.) or Attaclay<(R)> (Engelhard Corp., NJ, USA).

[000140] Bactericides may be added for preservation and stabilization of the compositions. Examples for suitable bactericides are those based on dichlorophene and benzylalcohol hemi formal (Proxel<(R)> from ICI or Acticide<(R)> RS from Thor Chemie and Kathon<(R)> MK from Rohm & Haas) and isothiazolinone derivatives such as alkylisothiazolinones and

benzisothiazolinones (Acticide<(R)> MBS from Thor Chemie).

[000141 ] Examples for suitable anti-freezing agents are ethylene glycol, propylene glycol, urea and glycerin.

[000142] Examples for anti-foaming agents are silicone emulsions (such as e. g. Silikon<(R)> SRE, Wacker, Germany or Rhodorsil<(R)>, Rhodia, France), long chain alcohols, fatty acids, salts of fatty acids, fluoroorganic compounds and mixtures thereof.

[000143] Examples for tackifiers or binders are polyvinylpyrrolidone, polyvinylacetates, polyvinyl alcohols and cellulose ethers (Tylose<(R)>, Shin-Etsu, Japan).

[000144] Examples of colorants are both sparingly water-soluble pigments and water-soluble dyes. Examples which may be mentioned are the dyes known under the names Rhodamin B, C.I. Pigment Red 1 12 and C.I. Solvent Red 1 , and also pigment blue 15:4, pigment blue 15:3, pigment blue 15:2, pigment blue 15:1 , pigment blue 80, pigment yellow 1 , pigment yellow 13, pigment red 1 12, pigment red 48:2, pigment red 48:1 , pigment red 57:1 , pigment red 53:1 , pigment orange 43, pigment orange 34, pigment orange 5, pigment green 36, pigment green 7, pigment white 6, pigment brown 25, basic violet 10, basic violet 49, acid red 51 , acid red 52, acid red 14, acid blue 9, acid yellow 23, basic red 10, basic red 108.

[000145] Powders, materials for spreading and dusts can be prepared by mixing or concomitantly grinding the compounds according to the present invention, or the salts thereof, and, if appropriate, further active substances, like other pesticides, with at least one solid carrier. Granules, e. g. coated granules, impregnated granules and homogeneous granules, can be prepared by binding the active substances to solid carriers.

[000146] Examples of solid carriers are mineral earths such as silica gels, silicates, talc, kaolin, attaclay, limestone, lime, chalk, bole, loess, clay, dolomite, diatomaceous earth, calcium sulfate, magnesium sulfate, magnesium oxide, ground synthetic materials, fertilizers, such as, e. g., ammonium sulfate, ammonium phosphate, ammonium nitrate, ureas, and products of vegetable origin, such as cereal meal, tree bark meal, wood meal and nutshell meal, cellulose powders and other solid carriers.

[000147] The compositions according to the present invention are herbicidal compositions because they contain the herbicidal compound clomazone. In addition to clomazone a second compound (B) is present in the compositions according to the present invention which is able to reduce the effective volatility of clomazone in the respective composition. Accordingly, the compound (B) in the compositions according to the present invention can be used, i.e. added for reducing the volatility of clomazone in the composition. [000148] In a preferred embodiment, the volatility of clomazone in the composition according to the present invention comprising compounds (A) and (B) prepared by the method hereby described is at least 5 % lower, preferably at least 10 % lower, more preferably at least 20 % lower, even more preferably 30 % lower, and most preferably at least 40 % lower, than the volatility of clomazone in the corresponding comparative composition in which only clomazone is present as compound (A) whereas compound (B) is absent. The relative reduction in volatility is measured by the loss of clomazone per time period, preferably at 25°C after 24 hours, in the composition according to the present invention comprising compounds (A) and (B) relative to the comparative composition in which compound (B) is absent. The amount of clomazone lost due to volatility can be preferably determined by GC using the experimental method as it is described in the method section below.

[000149] Since at least some of the compounds (B) additionally have independent herbicidal activity, preferably dimethenamid, pendimethalin, metolachlor, metazachlor and mixtures thereof, a synergistic effect can be achieved by combining clomazone with such additional herbicidal compounds because not only the herbicidal properties of at least two complementary herbicidal compounds are combined but, in addition, the volatility of clomazone is diminished by the additional presence of an additional compound like dimethenamid, pendimethalin, metolachlor and/or metazachlor, thereby additionally increasing the herbicidal activity of clomazone due to the prolonged presence of clomazone on the treated soil.

[000150] In another embodiment of the present invention, a process for the preparation of the compositions according to present invention is claimed. This preparation is suitable for preparing the compositions, preferably herbicidal compositions, comprising clomazone with significantly reduced volatility. The preparation process according to the present invention includes the steps of providing a compound (A) which is clomazone, and reducing the volatility of clomazone in said composition by adding to said composition the compound (B).

[000151 ] The preparation process is useful for obtaining compositions that contain clomazone in a form which is less volatile when compared to the same clomazone composition in which compound (B) is absent.

[000152] Additional preferred embodiments of the present invention are as follows:

[000153] A composition comprising the following compounds:

(A) clomazone, preferably non-encapsulated clomazone, and

(B) a compound defined by the following formula (I)

wherein the substituents R 1 , R 2 , R 3 , R 4 and X are defined as follows:

Ri is selected from hydrogen, linear or branched, saturated or unsaturated, optionally hydroxyl- substituted, alkyl, acyl and halogenated acyl,

R2 is independently selected from linear or branched alkyl, halogenated alkyl, hydroxylated alkyl, alkoxylated alkyl and N-1 H-pyrazol-1 -ylmethyl,

R3 is independently selected from aromatic or non-aromatic C(Rs) with substituent R 5 selected from hydrogen or linear or branched, saturated or unsaturated, optionally hydroxy-substituted Ci to C25 alkyl, C(Rs) preferably being selected from non-aromatic -C(Rs), aromatic CH, aromatic C-CH3, aromatic C-CH2-CH3, aromatic C-(CH 2 )2-CH 3 , aromatic C-C(CH 3 )-CH 3 ; aromatic C-CI, aromatic C-OH and aromatic C-NO2,

R 4 is independently selected from aromatic CH-CH-CH, aromatic C(CH3)-CH-CH, aromatic CH- C(CH 3 )-CH, aromatic CH-CH-C(CH 3 ), aromatic C(CH 3 )-C(CH 3 )-CH, aromatic C(CH 3 )-CH- C(CH 3 ), aromatic CH-C(CH 3 )-C(CH 3 ), aromatic CH-S , aromatic CH-O, or is absent, and X is independently selected from aromatic CH, aromatic C-CH 3 , aromatic C-CH2-CH 3 , aromatic C-(CH 2 ) 2 -CH 3 , aromatic C-CI, aromatic C-OH, aromatic C-NO2, O, NH, and S.

[000154] In another preferred embodiment of the present invention, the compound (B) is defined by the following formula (lla)

wherein R 1 and R 2 independently represent hydrogen or linear or branched, saturated or unsaturated, optionally hydroxy-substituted Ci to C12 alkyl, preferably methyl, ethyl, propyl or isopropyl and R 3 is non-aromatic CR 5 wherein R 5 is selected from linear or branched, saturated or unsaturated, optionally hydroxy-substituted C5 to C25 alkyl.

[000155] In another preferred embodiment of the present invention, the compound according to formula (lla) is selected from the fatty acid amides of capronic acid, caprylic acid, capric acid, lauric acid, myrystic acid, palmitic acid, stearic acid, isostearic acid, 12-hydroxy stearic acid, ricinoleic acid, oleic acid, linoleic acid, linolenic acid, gadoleic acid, arachidonic acid, erucic acid, behenic acid, ciric acid, lactic acid and the mixtures thereof, preferably the dimethyl fatty acid amides and their mixtures thereof.

[000156] In another preferred embodiment of the present invention, compound (B) is defined by the following formula (lib):

wherein Ri is selected from -H, -CH 3 , -CH 2 -CH 3 , -(CH 2 ) 2 -CH 3 , -C(CH 3 )-CH 3 , acyl, like formyl, acetyl, propionyl, halogenated acyl, like halogenated acetyl, halogenated propionyl, preferably CO-CH2CI, -CO-CHCI-CH 3 , -CO-CH2-CH2CI,

R2 is selected from linear or branched Ci to C6 alkyl, preferably methyl, ethyl propyl, butyl, pentyl, hexyl, isopropyl, isobutyl, sec-butyl, tert-butyl, 1 -ethyl propyl, 2-ethylpropyl, and chlorinated and/or hydroxylated derivatives thereof, and methoxylated or ethoxylated Ci to C6 alkyl, preferably methoxymethyl, 1 -methoxy-ethyl, 2-methoxy-ethyl, 1 -methoxy-1 -propyl, 2- methoxy-1 -propyl, 1 -methoxy-2-propyl, , 2-methoxy-2-propyl, 2-methoxy-3-propyl, 1 -ethoxy- ethyl, 2-ethoxy-ethyl, 1 -ethoxy-1 -propyl, 2-ethoxy-1 -propyl, 1 -ethoxy-2-propyl, , 2-ethoxy-2- propyl, 2-ethoxy-3-propyl, and N-(1 H-pyrazol-1 -ylmethyl,

R6, R7, Re and R9 are independently selected from linear or branched, saturated or unsaturated, optionally hydroxy-substituted Ci to C 6 alkyl, preferably -H, -CH 3 , -CH2-CH3, -(CH 2 )2-CH 3 , - C(CH 3 )-CH 3 , -CI, -OH or -NC-2,

Y is selected from aromatic CH, aromatic C(CH3), S, and O, and n is 0 or 1.

[000157] In another preferred embodiment of the present invention, the compound (B) is selected from the list of compounds consisting of the compounds according to the following formulae (Ilia), (1Mb), (Illc), (llld) and mixtures thereof:

[000158] In another preferred embodiment of the present invention, the compound (B) has water-solubility of not higher than 50 g/L, preferably not higher than 40 g/L.

[000159] In another preferred embodiment of the present invention, the compound (B) has vapor pressure of less than 1 Pa at ambient temperature.

[000160] In another preferred embodiment of the present invention, the compound (B) is a liquid at standard ambient temperature of 25°C and standard ambient pressure of 100 kPa or an amorphous solid.

[000161 ] In another preferred embodiment of the present invention, the ratio of (A) clomazone to compound (B) is from 1 :12 to 1 :0.5, preferably 1 :10 to 1 :3, more preferably 1 :7 to 1 :5, based on the weight of the compounds.

[000162] In another preferred embodiment of the present invention, the relative amount of compound (B) in the formulation for agricultural end use is not higher than 90 % by weight, preferably not higher than 80 % by weight, more preferably not higher than 70 % by weight, and most preferably not higher than 60 % by weight, based on the total weight of the composition.

[000163] In another preferred embodiment of the present invention, the clomazone is a non- encapsulated clomazone, preferably not encapsulated by a polymer.

[000164] In another preferred embodiment of the present invention, the composition is formulated as an emulsion, an emulsifiable concentrate, or a suspension.

[000165] In another preferred embodiment of the present invention, the use of compound (B) as defined above is claimed for reducing the volatility of clomazone in a herbicidal composition, wherein the reduction in volatility of clomazone in the herbicidal composition is at least 5 %, more preferably 10 %, even more preferably 20 %, even more preferably 30 %, and most preferably 40 %, relative to the volatility of clomazone in the herbicidal composition without compound (B).

[000166] In another preferred embodiment of the present invention, the use of compound (B) as defined above is claimed for reducing the volatility of clomazone in a herbicidal composition, comprising the step of adding the compound (B) to a herbicidal composition comprising clomazone.

[000167] In another preferred embodiment of the present invention, a process for the preparation of a composition is claimed comprising clomazone with reduced volatility including the steps of providing a compound (A) which is clomazone, and reducing the volatility of clomazone in said composition by adding to said composition the compound (B).

[000168] Examples: The present invention is further illustrated by the following examples which are however not intended to limit the scope of the present invention.

[000169] Methods: There are several methods that can be used to determine the volatility of a certain active ingredient, typically a pesticide as mentioned above and in particular of the herbicidal compound clomazone for which reduced volatility is demonstrated when contained in the compositions according to the present invention. Established volatility measurement methods are for instance disclosed in previous patent application WO 201 1/039172 A2 giving disclosure to three different approaches: The measurement of volatility by use of TGA, the determination of volatility in an open Petri dish and the determination of volatility using a bioassay. All those measurements are equally applicable for measuring the volatility of the compounds which are components in the compositions according to the present invention, particularly for the herbicidal compound clomazone whose volatility is reduced in the

compositions according to the present invention.

[000170] However, a preferred method for determining the volatility of the compounds contained in the compositions according to the present invention is carried out as follows: Glass tubes (internal diameter 23 mm) are immersed in a water bath at 25°C. In the bottom of each of the glass tubes 100 μΙ of spray solution (component A and B diluted in water at the

concentration that a farmer would typically spray) are applied with a pipette. A tube is inserted in the glass tube. The ending of the inserted tube stays 25 mm above the bottom of the glass tube (i.e. the test sample). Along the inserted tube, the air contained in each individual glass tube is constantly suctioned at 250 L/h for the whole system. All glass tubes are separated from the lid by spacers which ensure the inlet of fresh air to the glass tubes. After short time the test sample is evaporated. The system is stopped according to a defined sampling period, preferably after 24 hours. The glass tubes are taken out and washed with THF. The washing solution is analyzed by GC for the compound of interest, e.g. clomazone. The loss of compound is calculated in % of the total amount of compound applied in the initial 100 μΙ sample. The reference test samples for the quantification of the initial applied Clomazone contain also THF. Each value is generated from 3 to 4 independent measurements. This method allows determining the relative volatility of a certain compound depending on the additional compounds present in a certain composition.

[000171 ] Test experiment 1 : Influence of the presence of dimethenamid on the volatility of clomazone in herbicidal compositions

[000172] Following the test method from above, a wettable powder (WP) comprising clomazone has been studied in terms of the volatility of Clomazone as dependent of the addition of Dimethenamid and/or solvents typically used in agricultural formulations. The preparation of the test sample simulated the spray solution as it would be applied in the field. Non-encapsulated Clomazone (as WP formulation) was prepared at 100 g/ha with 200 L water/ha. Paraffinic oil, rapeseed oil methyl ester and the aromatic solvent were added at 335 g/ha, while Dimethenamid was added at 500 g/ha. For the solvents, an appropriate emulsifier system was added. The sample size was 100 μΙ. The volatility test was carried out at 25°C and the operating time was 24h.

The test samples were as follows:

Control CE1 CE2 CE3 IE1 IE2

Clomazone + + + + + +

(100 g/ha)

Dimethenamid - - - - + +

(500 g/ha)

Solvent - Paraffinic Rapeseed Aromatic Aromatic -

(335 g/ha) oil oil methyl Solvesso™200 Solvesso™200

ester ND * ND * 'complex mixture of aromatic C10-C13 hydrocarbons (Exxon Mobil Chemical).

The volatility of clomazone has been determined for each sample according to the method from above. The results are shown in Fig. 1.

[000173] Conclusions for test experiment 1 : Dimethenamid significantly reduces the volatility of clomazone in the composition while the tested solvents had little or no effect on volatility of clomazone.

[000174] Test experiment 2: Influence of dimethyl fatty acids amides on the volatility of clomazone in herbicidal compositions

[000175] Solvents typically used in crop protection agents were tested for comparative purposes. As comparison dimethenamid (dimethenamid P) was also tested, but differently from example 1 , the test sample solution was prepared at 335 g/ha.CE3 was included again. Two controls were included in the experiment. For the solvents, an appropriate emulsifier system was added. The volatility test was carried out at 25°C, the operating time was 24h. The sample size was 100 μΙ.

Solvent A: Aromatic Solvesso™150 ND * : aromatic C10 hydrocarbons (Exxon Mobil Chemical. Solvent B: Aromatic Solvesso™200 ND * : complex mixture of aromatic C10-C13 hydrocarbons).

[000176] Conclusions from test experiment 2: Dimethenamid and dimethyl amides of fatty acids are able to significantly reduce the volatility of clomazone in herbicidal compositions.

[000177] Test experiment 3: Influence of chain length in fatty acid amides on volatility of clomazone in herbicidal compositions

[000178] Various fatty acid amides were tested as additional components in herbicidal compositions with respect to the question if volatility of clomazone in such compositions is affected. For the solvents, an appropriate emulsifier system was added. The volatility test was carried out at 25°C, the operating time was 24h. The sample size was 100 μΙ.

Active ingredient Solvent / carboxylic acid amide

(100 g/ha) (335 g/ha)

IE4 Clomazone Dibutylpropionamide

IE5 Clomazone Mixture of C10 to C25 fatty acids, dimethyl amide

(Agnique AMD C10-C25)

IE6 Clomazone C12 fatty acid, dimethyl amide

(Agnique AMD C12)

IE7 Clomazone C10 fatty acid, dimethyl amide

(Aqnique KE 3308, AMD 10) IE8 Clomazone Mixture of C8, C10 fatty acids, dimethyl amide

(Agnique AMD 810)

IE9 Clomazone C8 fatty acid, dimethyl amide (Agnique AMD 8)

Control Clomazone No solvent, no carboxylic acid amide

[000179] Conclusions from test experiment 3: Dimethyl amides of carboxylic acids, particularly those of C10 fatty acid are able to significantly reduce the volatility of clomazone in herbicidal compositions.

[000180] Test experiment 4: Influence of standing time of the spray solution coming from the composition with respect to the volatility of clomazone

[000181 ] The effect of standing time of the spray solution on the volatility of clomazone depending on type of formulation was studied in this test experiment. The concentration of Clomazone was for all composition 100 g/ha (with 200 L water/ha). Dimethenamide was added at 500 g/ha. Spray solutions were prepared and added to the tubes after a standing time in the lab of 0, 3 and 6 hours, respectively. The volatility test was carried out at 25°C, the operating time was 24h. The sample size was 100 μΙ.

A: Nimbus®CS; B: Centium®CS; C: Centium®WP and Spectrum®

[000182] Conclusions from test experiment 4: The wetted powder formulation of clomazone to which dimethenamid was added in the tank has the lowest value for the measured volatility and also the most stable behaviour during extending standing times.

[000183] Test experiment 5: Reduction of volatility of clomazone in the presence of other herbicidal compounds (B)

[000184] As already reported in the above test experiments, under the identical measurement conditions and using the same test method for the volatility, the loss of Clomazone for Clomazone WP (solo) is at least 40 to 55 % after 24h at 25°C, i.e. much higher than the volatilities measured in test experiment 5.

[000185] Conclusions from test experiment 5: The additional alternative compounds (B) according to the present invention, Pendimethalin and Metalochlor, equally support the claimed reduction of volatility of Clomazone in the compositions according to the present invention.